<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28270747</article-id>
<article-id pub-id-type="pmc">5318388</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00034</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Ning</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/376981/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rho</surname>
<given-names>Jong M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/46865/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masino</surname>
<given-names>Susan A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/34187/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Departments of Pediatrics, University of Calgary</institution>
<country>Calgary, AB, Canada</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Clinical Neurosciences, University of Calgary</institution>
<country>Calgary, AB, Canada</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary</institution>
<country>Calgary, AB, Canada</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Neuroscience Program, Department of Psychology, Trinity College</institution>
<country>Hartford, CT, USA</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Kimberly Raab-Graham, Wake Forest School of Medicine, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Michael J. Schmeisser, Otto-von-Guericke University Magdeburg, Germany; Kasia Radwanska, Nencki Institute of Experimental Biology, Poland</p>
</fn>
<corresp id="fn001">*Correspondence: Ning Cheng <email xlink:type="simple">ncheng@ucalgary.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>34</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Cheng, Rho and Masino.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Cheng, Rho and Masino</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) is characterized by deficits in sociability and communication, and increased repetitive and/or restrictive behaviors. While the etio-pathogenesis of ASD is unknown, clinical manifestations are diverse and many possible genetic and environmental factors have been implicated. As such, it has been a great challenge to identify key neurobiological mechanisms and to develop effective treatments. Current therapies focus on co-morbid conditions (such as epileptic seizures and sleep disturbances) and there is no cure for the core symptoms. Recent studies have increasingly implicated mitochondrial dysfunction in ASD. The fact that mitochondria are an integral part of diverse cellular functions and are susceptible to many insults could explain how a wide range of factors can contribute to a consistent behavioral phenotype in ASD. Meanwhile, the high-fat, low-carbohydrate ketogenic diet (KD), used for nearly a century to treat medically intractable epilepsy, has been shown to enhance mitochondrial function through a multiplicity of mechanisms and affect additional molecular targets that may address symptoms and comorbidities of ASD. Here, we review the evidence for the use of metabolism-based therapies such as the KD in the treatment of ASD as well as emerging co-morbid models of epilepsy and autism. Future research directions aimed at validating such therapeutic approaches and identifying additional and novel mechanistic targets are also discussed.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>ketogenic diet</kwd>
<kwd>metabolism</kwd>
<kwd>mitochondria</kwd>
<kwd>therapeutics</kwd>
<kwd>epilepsy</kwd>
<kwd>co-morbidity</kwd>
<kwd>mechanism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Alberta Children's Hospital Foundation<named-content content-type="fundref-id">10.13039/501100003206</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn002">NS066392</award-id>
<award-id rid="cn002">AT008742</award-id>
<award-id rid="cn002">NS065957</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="178"></ref-count>
<page-count count="12"></page-count>
<word-count count="11134"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Autism spectrum disorder—complex etiology, limited therapies</title>
<p>Autism spectrum disorder (ASD) is characterized by persistent deficits in sociability and communication, as well as restricted and repetitive patterns of behavior and interests (DiCicco-Bloom et al., <xref ref-type="bibr" rid="B41">2006</xref>; Llaneza et al., <xref ref-type="bibr" rid="B96">2010</xref>; Lai et al., <xref ref-type="bibr" rid="B90">2014</xref>). The term “spectrum” refers to the wide range of symptoms and levels of impairment that can occur in individuals with ASD. Beyond these core behavioral symptoms, ASD is increasingly shown to affect the gastrointestinal, immune, hepatic, and endocrine systems (Goines and Van de Water, <xref ref-type="bibr" rid="B59">2010</xref>; Patterson, <xref ref-type="bibr" rid="B137">2011</xref>; Hsiao, <xref ref-type="bibr" rid="B65">2013</xref>; Frye et al., <xref ref-type="bibr" rid="B49">2015</xref>; Mayer et al., <xref ref-type="bibr" rid="B112">2015</xref>). Common co-morbidities include neurologic, psychiatric and physical conditions: neurologic comorbidities include epilepsy, sleep impairment, sensory abnormalities, and delays and/or deficits in motor function; psychiatric conditions such as depression, anxiety, irritability and attention deficit hyperactivity disorder; and physical health issues such as chronic gastrointestinal disturbance. The co-occurrence rate of one or more non-ASD developmental diagnoses is as high as 83% (Levy et al., <xref ref-type="bibr" rid="B93">2010</xref>).</p>
<p>ASD occurs in all racial, ethnic, and socioeconomic groups and is highly prevalent. It affects tens of millions individuals worldwide and costs millions of US dollars on average to support an affected individual during his/her lifespan (Buescher et al., <xref ref-type="bibr" rid="B18">2014</xref>). In the U.S., the incidence of ASD is 1 in 68 children (1 in 42 boys and 1 in 189 girls) based on data released by the Centers for Disease Control and Prevention (CDC) in 2014. The prevalence appears to be on the rise (a 10-fold increase in 40 years), and is explained only in part by improved diagnosis and awareness (Hansen et al., <xref ref-type="bibr" rid="B61">2015</xref>). Developmental delay in ASD can be detected as early as 6 months of age, a critical time for the development of higher-order social, emotional, and communications functions (Courchesne et al., <xref ref-type="bibr" rid="B32">2007</xref>); the importance of early intervention is recognized (Orinstein et al., <xref ref-type="bibr" rid="B133">2014</xref>). However, on average, children are not diagnosed until after 4 years of age (CDC, <xref ref-type="bibr" rid="B20">2014</xref>), even though patients can now be reliably diagnosed at 2 years of age (Lord et al., <xref ref-type="bibr" rid="B98">2006</xref>; Kleinman et al., <xref ref-type="bibr" rid="B83">2008</xref>).</p>
<p>Given that ASD has broad and heterogeneous manifestations, and has been associated with a plethora of possible etiological factors (both genetic and environmental), ASD remains a clinical and broad-spectrum diagnosis. In most cases, ASD is diagnosed without any defined etiology. A dearth of knowledge about underlying causes has limited the ability to develop and mobilize effective treatments, and currently only co-morbid manifestations of the disorder can be alleviated. The hope is that reducing co-morbidities such as epileptic seizures, psychiatric disturbances, hyperactivity, sleep problems and digestive issues (DiCicco-Bloom et al., <xref ref-type="bibr" rid="B41">2006</xref>; Llaneza et al., <xref ref-type="bibr" rid="B96">2010</xref>; Lai et al., <xref ref-type="bibr" rid="B90">2014</xref>) will improve overall function and reduce the severity of ASD symptoms (Kohane et al., <xref ref-type="bibr" rid="B84">2012</xref>; Frye and Rossignol, <xref ref-type="bibr" rid="B51">2016</xref>).</p>
<p>Genetic susceptibility factors and environmental influences (and likely often both) contribute to ASD (Chaste and Leboyer, <xref ref-type="bibr" rid="B24">2012</xref>; Sandin et al., <xref ref-type="bibr" rid="B154">2014</xref>; Tordjman et al., <xref ref-type="bibr" rid="B167">2014</xref>; Kim and Leventhal, <xref ref-type="bibr" rid="B78">2015</xref>). Genome screening and sequencing has identified rare chromosomal abnormalities and copy number variations, as well as hundreds of rare gene mutations associated with autism (Devlin and Scherer, <xref ref-type="bibr" rid="B39">2012</xref>; Huguet et al., <xref ref-type="bibr" rid="B66">2013</xref>; Jeste and Geschwind, <xref ref-type="bibr" rid="B71">2014</xref>; Baker and Jeste, <xref ref-type="bibr" rid="B7">2015</xref>). A small number of these genetic changes appear highly penetrant and sufficient to cause autism. However, most genetic factors only increase the risk to varying degrees, and likely combine with additional influences such as advanced parental age at time of conception, adverse metabolic conditions and/or maternal illness during pregnancy, birth complications, and exposure to toxins and/or drugs during early brain development (Stromland et al., <xref ref-type="bibr" rid="B161">1994</xref>; Durkin et al., <xref ref-type="bibr" rid="B42">2008</xref>; Gardener et al., <xref ref-type="bibr" rid="B53">2011</xref>; Krakowiak et al., <xref ref-type="bibr" rid="B86">2012</xref>; Christensen et al., <xref ref-type="bibr" rid="B28">2013</xref>). Not surprisingly, the molecular pathways implicated in ASD are also highly complex and diverse, and include synaptic dysfunction and plasticity of various neurotransmitter systems, transcriptional regulation and chromatin remodeling, protein translation and modification, neuroimmunological modulation, and mitochondrial function (Veenstra-Vanderweele et al., <xref ref-type="bibr" rid="B169">2004</xref>; Bourgeron, <xref ref-type="bibr" rid="B15">2015</xref>; De Rubeis and Buxbaum, <xref ref-type="bibr" rid="B38">2015</xref>; Kopp et al., <xref ref-type="bibr" rid="B85">2015</xref>; Loke et al., <xref ref-type="bibr" rid="B97">2015</xref>; Mahfouz et al., <xref ref-type="bibr" rid="B103">2015</xref>; Nelson and Valakh, <xref ref-type="bibr" rid="B127">2015</xref>; Subramanian et al., <xref ref-type="bibr" rid="B163">2015</xref>; de la Torre-Ubieta et al., <xref ref-type="bibr" rid="B37">2016</xref>; Wen et al., <xref ref-type="bibr" rid="B172">2016</xref>).</p>
</sec>
<sec id="s2">
<title>Metabolism, mitochondria, and ASD</title>
<p>Given such extreme etiological diversity, it is reasonable to hypothesize that perturbation of a common nexus can precipitate the behavioral hallmarks of ASD (Geschwind, <xref ref-type="bibr" rid="B56">2008</xref>; Berg and Geschwind, <xref ref-type="bibr" rid="B10">2012</xref>). Identifying such a common factor would provide novel insights into the development of ASD. Further, targeting this pathway could lead to selective therapeutic approaches that might enhance efficacy and address core symptoms. One possibility is mitochondrial function, which is integral to many cellular pathways. In addition to its well-known role as the “powerhouse of the cell,” producing the bulk of the cellular energy, mitochondria are also critically involved in cellular metabolism, intracellular calcium signaling, generation of reactive oxygen species (ROS), and apoptosis (Suen et al., <xref ref-type="bibr" rid="B164">2008</xref>; Murphy, <xref ref-type="bibr" rid="B119">2009</xref>; Palmieri et al., <xref ref-type="bibr" rid="B134">2010</xref>; Antico Arciuch et al., <xref ref-type="bibr" rid="B6">2012</xref>; Rizzuto et al., <xref ref-type="bibr" rid="B145">2012</xref>), as well as in the regulation of innate and adaptive immunity (Weinberg et al., <xref ref-type="bibr" rid="B171">2015</xref>). For example, mitochondria carry out both cleavage and synthesis of glycine (Kikuchi et al., <xref ref-type="bibr" rid="B76">2008</xref>), which is the ligand of glycine receptors. These receptors are chloride channels that mediate inhibitory neurotransmission in the adult nervous system. However, they are highly expressed in the embryonic brain and mediate excitatory neurotransmission, and are believed to promote cortical interneuron migration and generation of excitatory projection neurons (Pilorge et al., <xref ref-type="bibr" rid="B140">2016</xref>). Interestingly, recent genetic and functional studies have identified a role of abnormal glycinergic signaling in ASD (Pilorge et al., <xref ref-type="bibr" rid="B140">2016</xref>). Furthermore, mitochondria are known to be affected by many of the same endogenous and exogenous risk factors of ASD, such as toxins, drugs, immune activation, and metabolic disturbances (Frye and Rossignol, <xref ref-type="bibr" rid="B50">2011</xref>). Thus, elucidating the role of mitochondrial dysfunction in ASD may help unify our understanding of this complex disorder.</p>
<p>Mitochondria play a particularly vital role in the central nervous system. The brain has very high energy demands, consuming approximately 20% of calories while accounting for only 2% of total body weight (Raichle and Gusnard, <xref ref-type="bibr" rid="B143">2002</xref>), and demanding a great amount of adenosine triphosphate (ATP) to maintain ionic gradients essential for neurotransmission and plasticity (Harris et al., <xref ref-type="bibr" rid="B62">2012</xref>). In addition, mitochondria are involved in the proliferation, differentiation and maturation of neural stem cells, formation of dendritic processes, developmental and synaptic plasticity, and cell survival and death (Li et al., <xref ref-type="bibr" rid="B94">2004</xref>; Kann and Kovacs, <xref ref-type="bibr" rid="B74">2007</xref>; Mattson et al., <xref ref-type="bibr" rid="B111">2008</xref>; Kimura and Murakami, <xref ref-type="bibr" rid="B82">2014</xref>; Xavier et al., <xref ref-type="bibr" rid="B174">2016</xref>). Thus, it is not surprising that multiple lines of evidence in both human and animal models support a role for mitochondrial dysfunction in the etiology of ASD (Haas, <xref ref-type="bibr" rid="B60">2010</xref>; Dhillon et al., <xref ref-type="bibr" rid="B40">2011</xref>; Frye and Rossignol, <xref ref-type="bibr" rid="B50">2011</xref>; Rossignol and Frye, <xref ref-type="bibr" rid="B148">2012</xref>; Legido et al., <xref ref-type="bibr" rid="B92">2013</xref>).</p>
<p>The prevalence of mitochondrial disease in the ASD population is estimated to be about 5.0%, 500 times higher than that found in the general population (≈0.01%). The prevalence of abnormal metabolic biomarkers is even higher, suggesting that as many as 30% of children with ASD may experience metabolic abnormalities: almost one-third of autistic children have documented elevations in plasma lactate and/or the lactate-to-pyruvate ratio, and the levels of many other mitochondrial biomarkers (pyruvate, carnitine, and ubiquinone) are significantly different between ASD and controls (Rossignol and Frye, <xref ref-type="bibr" rid="B148">2012</xref>). In addition, several genes known to regulate mitochondrial function are clearly autism-risk genes. These include <italic>SLC25A12</italic> (Ramoz et al., <xref ref-type="bibr" rid="B144">2004</xref>; Segurado et al., <xref ref-type="bibr" rid="B156">2005</xref>; Silverman et al., <xref ref-type="bibr" rid="B157">2008</xref>; Turunen et al., <xref ref-type="bibr" rid="B168">2008</xref>; Kim et al., <xref ref-type="bibr" rid="B77">2011</xref>), which encodes the predominant form of mitochondrial aspartate/glutamate carrier (however, also see Correia et al., <xref ref-type="bibr" rid="B31">2006</xref>; Palmieri et al., <xref ref-type="bibr" rid="B134">2010</xref>). These carriers participate in a wide range of mitochondrial functions, including control of respiration, calcium signaling and antioxidant defense, as well as glutamate-mediated excitotoxicity (Amoedo et al., <xref ref-type="bibr" rid="B5">2016</xref>). Furthermore, <italic>TMLHE</italic>, (trimethyllysine hydroxylase epsilon), which encodes the first enzyme in carnitine biosynthesis, has also been associated with ASD (Celestino-Soper et al., <xref ref-type="bibr" rid="B21">2012</xref>; Nava et al., <xref ref-type="bibr" rid="B122">2012</xref>). It has been well established that carnitines are involved in mitochondrial transport of long-chain fatty acids and play an important role in maintaining normal mitochondrial function (Bremer, <xref ref-type="bibr" rid="B16">1983</xref>). In addition, the gene encoding an inner mitochondrial membrane protease-like protein (<italic>IMMP2L</italic>) may help regulate susceptibility to ASD (Maestrini et al., <xref ref-type="bibr" rid="B102">2010</xref>). It is important to note that metabolic and mitochondrial dysfunction may not exist in all patients with ASD, and biomarkers to identify this impairment would be advantageous in developing personalized treatment.</p>
<p>In parallel with clinical findings, many animal models of ASD also display mitochondrial dysfunction, including those based on susceptibility genes such as <italic>MECP2, UBE3A, TSC</italic>, and <italic>FOXG1</italic>. Mitochondrial dysfunction has also been observed in animal models of ASD induced by environmental risk factors such as maternal immune activation and exposure to propionic acid or valproic acid (VPA). Current evidence linking mitochondrial perturbations to ASD and the corresponding references are summarized in Tables <xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>Studies showing linkage between ASD and mitochondrial dysfunction in ASD patients (only those reporting more than 25 subjects are included in this table)</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Cases</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Evidence of mitochondrial dysfunction</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>GENETIC LINKAGE BETWEEN MITOCHONDRIA-RELATED GENES AND AUTISM</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Celestino-Soper et al., <xref ref-type="bibr" rid="B21">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">909 or 130</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficiency of the gene <italic>TMLHE</italic> (trimethyl-lysine hydroxylase epsilon), which encodes the first enzyme in carnitine biosynthesis, was more frequent in probands from male-male multiplex ASD families.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Glessner et al., <xref ref-type="bibr" rid="B57">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">859</td>
<td align="left" colspan="1" rowspan="1" valign="top">Copy number variations in genes involved in the ubiquitin degradation were implicated in susceptibility for ASD.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kent et al., <xref ref-type="bibr" rid="B75">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">129</td>
<td align="left" colspan="1" rowspan="1" valign="top">The 3243A&gt;G mitochondrial DNA mutation was concluded to be a rare cause of isolated Asperger syndrome.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Silverman et al., <xref ref-type="bibr" rid="B157">2008</xref>; Kim et al., <xref ref-type="bibr" rid="B77">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple families</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism in <italic>SLC25A12</italic> gene, which encodes a mitochondrial aspartate/glutamate carrier, was found to be associated with restricted repetitive behaviors in autism.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Maestrini et al., <xref ref-type="bibr" rid="B102">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">127</td>
<td align="left" colspan="1" rowspan="1" valign="top">A gene encoding an inner mitochondrial membrane protease-like protein (<italic>IMMP2L)</italic> was implicated in susceptibility for ASD.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nava et al., <xref ref-type="bibr" rid="B122">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">501</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mutations in <italic>TMLHE</italic> were identified in patients with ASD and led to an increase in trimethyl-lysine, the precursor of carnitine biosynthesis, in the plasma.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ramoz et al., <xref ref-type="bibr" rid="B144">2004</xref>; Segurado et al., <xref ref-type="bibr" rid="B156">2005</xref>; Turunen et al., <xref ref-type="bibr" rid="B168">2008</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple families</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism in <italic>SLC25A12</italic> gene was found to be associated with autism.</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>INDICATIONS OF IMPAIRED MITOCHONDRIAL FUNCTION IN THE BRAIN</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Goh et al., <xref ref-type="bibr" rid="B58">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">75</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lactate doublets detected by brain magnetic resonance spectroscopic imaging were present at a higher rate in autistic patients.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Palmieri et al., <xref ref-type="bibr" rid="B134">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Six or multiple families</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transport rates of mitochondrial aspartate/glutamate carrier (AGC) were higher in temporo-cortical gray matter. In addition, expression of AGC1, cytochrome c oxidase activity, and oxidized mitochondrial proteins were increased. However, variants of the AGC1-encoding <italic>SLC25A12</italic> gene were not correlated with AGC activation or autism phenotype.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tang et al., <xref ref-type="bibr" rid="B165">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">45</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial function and intracellular redox status were compromised in the pyramidal neurons of the temporal cortex.</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>ABNORMAL LEVELS OF MITOCHONDRIA-RELATED METABOLITES IN BLOOD SAMPLES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Al-Mosalem et al., <xref ref-type="bibr" rid="B3">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">30</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased plasma lactate levels and activity of creatine kinase.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cohen et al., <xref ref-type="bibr" rid="B30">1976</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">25</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased serum creatine phosphokinase levels.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Correia et al., <xref ref-type="bibr" rid="B31">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">241</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased plasma lactate levels and lactate/pyruvate ratio, but not associated with the variation at the <italic>SLC25A12</italic> gene.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Filipek et al., <xref ref-type="bibr" rid="B45">2004</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced levels of carnitine and pyruvate, but increased levels of alanine and ammonia in serum.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Frye et al., <xref ref-type="bibr" rid="B48">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">213</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal acyl-carnitine panels and glutathione metabolism in blood samples.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kuwabara et al., <xref ref-type="bibr" rid="B89">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">25</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher plasma levels of arginine and taurine, and lower levels of 5-oxoproline and lactic acid.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">László et al., <xref ref-type="bibr" rid="B91">1994</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">30</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased serum lactate and pyruvate levels.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Moreno et al., <xref ref-type="bibr" rid="B116">1992</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">60</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased lactate and pyruvate levels.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oliveira et al., <xref ref-type="bibr" rid="B132">2005</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">69</td>
<td align="left" colspan="1" rowspan="1" valign="top">20% of ASD patients showed significantly increased lactic acidemia, while 7% were classified with a definite mitochondrial respiratory chain disorder.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Poling et al., <xref ref-type="bibr" rid="B141">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">159</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased blood aspartate aminotransferase and creatine kinase levels.</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>ABNORMAL MITOCHONDRIAL FUNCTION AND DNA STRUCTURE IN PERIPHERAL CELLS OR CELL LINES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Boccuto et al., <xref ref-type="bibr" rid="B12">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">87</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased tryptophan metabolism in lymphoblastoid cell lines.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B25">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">78</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial DNA copy number in peripheral blood cells was elevated in children with ASD.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rose et al., <xref ref-type="bibr" rid="B146">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">43</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary immune cells in the blood had a more oxidized intracellular and extracellular microenvironment and a deficit in glutathione-mediated redox/antioxidant capacity.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rose et al., <xref ref-type="bibr" rid="B147">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">25</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial dysfunction observed in a subset of autism lymphoblastoid cell lines.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wong et al., <xref ref-type="bibr" rid="B173">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">66</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial DNA deletions and higher p53 gene copy ratios in peripheral blood monocytic cells were more common in children with autism and their fathers.</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p><bold>Studies showing association between ASD and mitochondrial dysfunction in animal models of ASD</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Evidence of mitochondrial dysfunction</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>LINKAGE BETWEEN MITOCHONDRIA-RELATED GENES AND AUTISTIC PHENOTYPE</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hullinger et al., <xref ref-type="bibr" rid="B67">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased expression of AT-1/SLC33A1 caused an autistic-like phenotype in mice.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inan et al., <xref ref-type="bibr" rid="B69">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Progressive decline in oxidative phosphorylation led to circuit dysfunction, impaired sensory gating and social disability when the <italic>cox10</italic> gene was selectively deleted in parvalbumin neurons in mouse.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B153">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Loss of <italic>SLC25A12</italic> gene resulted in hypomyelination. Myelin deficits in slice cultures from knockout mice were reversed by administration of pyruvate.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Xie et al., <xref ref-type="bibr" rid="B175">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell-autonomous insufficiencies in the activity of <italic>TMLHE</italic> reduced neural stem cell pools in the embryonic mouse brain.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zhao et al., <xref ref-type="bibr" rid="B178">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-like features observed in neuronal glucose transporter isoform 3-deficient mice.</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>ALTERATIONS IN MITOCHONDRIAL FUNCTION IN ANIMAL OR CELLULAR MODELS OF ASD BASED ON GENETIC FACTORS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">De Filippis et al., <xref ref-type="bibr" rid="B36">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">The rate of hydrogen peroxide generation was increased and the function of complex ii impaired in the brain of <italic>MeCP2-</italic>308 heterozygous female mice.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Jin et al., <xref ref-type="bibr" rid="B72">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Mecp2</italic>, whose mutations cause Rett syndrome, was observed to regulate mitochondrial bioenergetics through a glutamine transporter in microglia.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kriaucionis et al., <xref ref-type="bibr" rid="B87">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial abnormalities observed in <italic>Mecp2</italic>-null mouse, a model of Rett syndrome.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nie et al., <xref ref-type="bibr" rid="B129">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial uncoupling protein-2 was highly induced in <italic>Tsc2</italic>-deficient neurons, and also in a neuron-specific <italic>Tsc1</italic> conditional knock-out mouse model.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Norkett et al., <xref ref-type="bibr" rid="B130">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">DISC1 protein regulated mitochondrial dynamics in neurites of neurons.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pancrazi et al., <xref ref-type="bibr" rid="B135">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">A fraction of the protein Foxg1, which is implicated in autism, was found to localize to mitochondria and coordinate cell differentiation and bioenergetics.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Santini et al., <xref ref-type="bibr" rid="B155">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">A mouse model of Angelman syndrome displayed elevated levels of mitochondria-derived reactive oxygen species in pyramidal neurons in hippocampal CA1 area, and administration of MitoQ, a mitochondria-specific antioxidant, to this model normalized synaptic plasticity and restored memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Su et al., <xref ref-type="bibr" rid="B162">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial dysfunction observed in hippocampal neurons of the <italic>UBE3A</italic>-deficient mouse model of Angelman syndrome.</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>MITOCHONDRIAL DYSFUNCTION IN ANIMAL MODELS OF ASD BASED ON ENVIRONMENTAL FACTORS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bhandari and Kuhad, <xref ref-type="bibr" rid="B11">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Propanoic acid exposure induced autism-like behavior in rats and activities of complex I and II were reduced.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kumar and Sharma, <xref ref-type="bibr" rid="B88">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Prenatal exposure to valproic acid decreased the activity of mitochondrial complex I, II, and IV in rats.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Macfabe, <xref ref-type="bibr" rid="B101">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial dysfunction observed in a rat ASD model in which propionic acid, an enteric bacterial fermentation product, is infused intracerebroventricularly.</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>TREATMENT RELATED TO METABOLISM AND MITOCHONDRIAL FUNCTION IN ANIMAL MODELS OF ASD<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ciarlone et al., <xref ref-type="bibr" rid="B29">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Ketone ester supplementation improved motor coordination, learning and memory, and synaptic plasticity in a mouse model of Angelman syndrome. The treatment also attenuated seizure activity and altered brain amino acid metabolism in this model.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Currais et al., <xref ref-type="bibr" rid="B34">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Dietary glycemic index was found to modulate behavioral and biochemical phenotype of the BTBR mouse model of ASD.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Naviaux et al., <xref ref-type="bibr" rid="B123">2013</xref>, <xref ref-type="bibr" rid="B124">2014</xref>, <xref ref-type="bibr" rid="B125">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Anti-purinergic therapy improved autism-like features in the maternal immune activation mouse model and the Fragile X mouse model.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Park et al., <xref ref-type="bibr" rid="B136">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Dietary therapy with triheptanoin enhanced mitochondrial substrate use and improved metabolism and behaviors of <italic>Mecp2</italic>-null mouse model of Rett syndrome.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B153">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Loss of the <italic>SLC25A12</italic> gene resulted in hypomyelination. Myelin deficits in slice cultures from knockout mice are reversed by administration of pyruvate.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Santini et al., <xref ref-type="bibr" rid="B155">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">A mouse model of Angelman syndrome displayed elevated levels of mitochondria-derived reactive oxygen species in pyramidal neurons in CA1 hippocampus, and administration of MitoQ, a mitochondria-specific antioxidant, in this model normalized synaptic plasticity and restored memory.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>*</label>
<p><italic>Studies using the ketogenic diet are described in more detail in the main text</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Common co-morbidities of ASD also suggest metabolic and mitochondrial dysfunction. One of the most significant co-morbidities is epilepsy, with a prevalence of 5–38% in children with ASD—much higher than the 1–2% prevalence in the general population (Frye, <xref ref-type="bibr" rid="B47">2015</xref>). Seizures also occur in 35–60% of individuals with biochemically-confirmed mitochondrial disease (Rahman, <xref ref-type="bibr" rid="B142">2012</xref>), suggesting there may be a common etio-pathology. Similarly, gastrointestinal dysfunction, a frequent comorbidity of ASD (Chaidez et al., <xref ref-type="bibr" rid="B22">2014</xref>), is also common in mitochondrial disease (Frye et al., <xref ref-type="bibr" rid="B49">2015</xref>).</p>
<p>Taken together, we believe that mitochondria act as a central nexus responding to and regulating many domains of cellular biology that have been implicated in ASD. Given the prevalence of metabolic/mitochondrial dysfunction in ASD, options for metabolic therapy should be explored. Below we review some of the emerging clinical and research evidence that metabolic therapy and improved mitochondrial function can ameliorate ASD symptoms and comorbidities.</p>
</sec>
<sec id="s3">
<title>Metabolic therapy for ASD</title>
<p>A metabolic therapy in use for decades is the ketogenic diet (KD), a high-fat, low-carbohydrate diet—a remarkably effective non-pharmacological treatment for medically intractable epilepsy (Neal et al., <xref ref-type="bibr" rid="B126">2008</xref>). Based on historical observations that either fasting or starvation rendered anti-seizure effects, the KD was designed to reproduce the biochemical changes seen in these physiological states (Masino and Rho, <xref ref-type="bibr" rid="B109">2012</xref>). Recently, various dietary and metabolic therapies have been attempted in a wider variety of neurological diseases including ASD, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, sleep disorders, multiple sclerosis, brain trauma, stroke, pain, Huntington's disease and brain cancer (Ruskin et al., <xref ref-type="bibr" rid="B151">2009</xref>; Stafstrom and Rho, <xref ref-type="bibr" rid="B160">2012</xref>; Napoli et al., <xref ref-type="bibr" rid="B121">2014</xref>). Although generally limited in scope, clinical studies thus far showed promising results in conditions such as Alzheimer's disease and ASD and are discussed in more detail below. In addition, research using animal models has pointed to a common mechanism of regulating energy metabolism to afford neuroprotective effects (Stafstrom and Rho, <xref ref-type="bibr" rid="B160">2012</xref>).</p>
<p>Overall, recent clinical and laboratory evidence suggests that the KD may have positive effects in ASD. The complex pathophysiology of ASD and the diversity of mechanisms mobilized by dietary therapy combine to make identifying the key molecular mechanisms challenging, but a number of candidates are emerging. Two hallmark biochemical features after the KD treatment are increased ketone body production by the liver through fatty acid oxidation and reduced blood glucose levels (Stafstrom and Rho, <xref ref-type="bibr" rid="B160">2012</xref>). More specific metabolic effects, such as increases in specific polyunsaturated fatty acids, might regulate neuronal membrane excitability (Voskuyl and Vreugdenhil, <xref ref-type="bibr" rid="B170">2001</xref>), reduce inflammation (Cullingford, <xref ref-type="bibr" rid="B33">2008</xref>; Jeong et al., <xref ref-type="bibr" rid="B70">2011</xref>), or decrease the production of ROS by mitochondria (Kim do and Rho, <xref ref-type="bibr" rid="B80">2008</xref>). Additionally, ketone bodies themselves have been shown to possess neuroprotective properties through improved bioenergetics - raising ATP levels and reducing ROS production through enhancement of NADH oxidation and inhibition of mitochondrial permeability transition (Kim do et al., <xref ref-type="bibr" rid="B79">2007</xref>, <xref ref-type="bibr" rid="B81">2015</xref>); related to this, a KD has also been shown to stimulate mitochondrial biogenesis (Bough et al., <xref ref-type="bibr" rid="B14">2006</xref>; Ahola-Erkkila et al., <xref ref-type="bibr" rid="B2">2010</xref>). In parallel, reduced glycolysis can suppress seizures, improve mitochondrial function, decrease oxidative stress, reduce activity of pro-apoptotic factors, and inhibit inflammatory mediators such as interleukins and tumor necrosis factor alpha (Garriga-Canut et al., <xref ref-type="bibr" rid="B54">2006</xref>; Maalouf et al., <xref ref-type="bibr" rid="B100">2009</xref>). The KD has also been proposed to increase adenosine (a product of extracellular ATP dephosphorylation); ATP and adenosine are purines with pleiotropic neuromodulatory and neuroprotective roles proposed to underlie in part the diet's clinical efficacy (Masino and Geiger, <xref ref-type="bibr" rid="B105">2008</xref>; Masino et al., <xref ref-type="bibr" rid="B108">2009</xref>, <xref ref-type="bibr" rid="B107">2010</xref>). Separately, increased adenosine has been proposed to reduce symptoms and comorbidities of ASD (Masino et al., <xref ref-type="bibr" rid="B106">2013</xref>). In addition, the KD has been reported to regulate energy-sensing pathways such as those involving the insulin-like growth factor and the mammalian target of rapamycin (McDaniel et al., <xref ref-type="bibr" rid="B113">2011</xref>; Gano et al., <xref ref-type="bibr" rid="B52">2014</xref>). Epigenetic regulation is a new but potentially important mechanism as well (Boison, <xref ref-type="bibr" rid="B13">2016</xref>).</p>
<p>Given the effects of the KD and its substrates (e.g., ketone bodies, fatty acids) on cognitive and behavioral functioning, it is reasonable to speculate that this diet would induce changes in synaptic morphology and function. Studies have shown that the KD can modulate excitability through actions on potassium ion channels (Tigerholm et al., <xref ref-type="bibr" rid="B166">2012</xref>; Lutas and Yellen, <xref ref-type="bibr" rid="B99">2013</xref>) and glutamatergic synaptic transmission (Xu et al., <xref ref-type="bibr" rid="B176">2006</xref>; Juge et al., <xref ref-type="bibr" rid="B73">2010</xref>; Lutas and Yellen, <xref ref-type="bibr" rid="B99">2013</xref>; Chang et al., <xref ref-type="bibr" rid="B23">2016</xref>), as well as possible regulation of GABA production (Yudkoff et al., <xref ref-type="bibr" rid="B177">2007</xref>). In addition, the KD or its metabolic mediators can induce changes in synaptic vesicular cycling (Hrynevich et al., <xref ref-type="bibr" rid="B64">2016</xref>), hippocampal mossy fiber sprouting (Muller-Schwarze et al., <xref ref-type="bibr" rid="B118">1999</xref>), and both age- and region-dependent changes in synaptic morphology (Balietti et al., <xref ref-type="bibr" rid="B9">2008</xref>, <xref ref-type="bibr" rid="B8">2009</xref>).</p>
<p>Collectively, evidence thus far indicates that the KD affords broad neuroprotective effects, and hence, it is reasonable to hypothesize that this diet could prove to be beneficial for individuals with ASD.</p>
</sec>
<sec id="s4">
<title>Metabolic therapy and ASD—clinical evidence to date</title>
<p>To date, there have been limited clinical trials involving treatment of ASD patients with metabolic therapy using variants of a KD. The first report was a pilot prospective study in autistic children aged between 4 and 10 years carried out by Evangeliou and colleagues; they applied an intermittent modified medium-chain triglyceride (MCT) diet (Evangeliou et al., <xref ref-type="bibr" rid="B44">2003</xref>). Most of the 18 patients who adhered to the diet improved based on the Childhood Autism Rating Scale (CARS) and several additional clinical parameters. Significant (i.e., &gt;12 units of decrease in CARS) and average (&gt;8–12 units of decrease in CARS) improvement was recorded in two and eight patients, respectively, while minor (2–8 units of decrease in CARS) improvement was reported in the remaining eight patients. More recently, Spilioti and colleagues reported the effects of KD treatment in a group of Greek children with ASD aged between 3.5 and 6 years (Spilioti et al., <xref ref-type="bibr" rid="B159">2013</xref>). Of the 6 patients who implemented the diet successfully, significant and average improvement was recorded in one and two patients, respectively, and minor improvement was reported in the remaining three patients.</p>
<p>The diet is also effective in reducing common comorbidities of ASD such as seizures, not surprisingly, but also improved cognition and behavior. A pilot retrospective study analyzed outcomes in children prescribed the KD to treat epileptic seizures; among these children, some also had autistic symptoms and abnormal behaviors. Children assigned in the KD group were currently on the diet and had been for at least 6 months; children assigned in the non-KD group stopped the diet at least 2 months prior. Fewer abnormal behaviors and significant behavioral improvement were found in the KD group, and behavioral improvement was not correlated with seizure control (Masino et al., <xref ref-type="bibr" rid="B110">2011</xref>). More recently a randomized control trial showed improved cognition, mood and behavior—particularly reduced anxiety—in children prescribed the KD for refractory epilepsy. These behavioral benefits were also unrelated to seizure control (IJff et al., <xref ref-type="bibr" rid="B68">2016</xref>). In a remarkable case study, Herbert and Buckley reported on a 12-year-old child with comorbid autism and epilepsy treated with a gluten- and casein-free KD (fats composed mostly of MCTs) (Herbert and Buckley, <xref ref-type="bibr" rid="B63">2013</xref>). In addition to a significant reduction in seizures, the diet resolved morbid obesity and improved cognitive and behavioral function. Over the course of several years following initial diagnosis, the child's CARS score decreased from 49 to 17, representing a change from severe autism to a non-autistic state, and her intelligence quotient increased by 70 points.</p>
<p>In summary, clinical evidence to date remains limited, but results from the aforementioned studies show promise that metabolic therapy with several different versions of a KD can improve symptoms of ASD and can also improve cognition and behavior—the latter benefits that can facilitate optimal outcomes in ASD. In patients with diagnosed ASD, greater than 50% of autism patients who received this metabolic therapy showed moderate-to-significant clinical improvement, while the remainder displayed minor improvement. At present, more larger-scale clinical studies are required. Meanwhile, as mentioned earlier, metabolic and mitochondrial dysfunction may represent only a subgroup of the ASD population. Thus, it would be important to determine the relation between the effects of the KD and metabolic/genetic profile of ASD patients.</p>
</sec>
<sec id="s5">
<title>Metabolic therapy and ASD—evidence from animal models</title>
<p>Due to the complexity of ASD, investigators have developed and employed numerous animal models. Some have clear metabolic underpinnings, underscoring the link between metabolic dysfunction and symptoms of autism. Metabolic therapy with a KD and/or a restricted diet has already been examined in several models. In agreement with the aforementioned clinical studies, reports in animal models have been positive. The ASD models tested with metabolic therapy discussed here include genetic disorders that mirror clinical conditions, induced ASD that models environmental conditions found to increase ASD risk in humans, and behavioral ASD models with unknown etiologies that recapitulate all or some of the core symptoms, and may or may not have comorbid seizures.</p>
<p>As one genetic example, succinic semialdehyde dehydrogenase (SSADH) deficiency is a rare autosomal recessive condition that results in mild-to-moderate mental retardation, disproportionate language dysfunction, seizures, hypotonia, hyporeflexia, hallucinations, and autistic behaviors (Pearl et al., <xref ref-type="bibr" rid="B138">2003</xref>). In an animal model of SSADH deficiency, the SSADH knockout mouse, Nylen and colleagues found that KD treatment normalized electroencephalogram (EEG) activity and restored miniature inhibitory post-synaptic currents recorded in CA1 pyramidal cells using hippocampal slices. In contrast, there were no significant differences between the groups in terms of miniature excitatory post-synaptic currents. Behaviorally, KD-treated mutant animals experienced significantly fewer seizures compared to mutant animals fed the control diet (Nylen et al., <xref ref-type="bibr" rid="B131">2008</xref>).</p>
<p>Metabolic therapy with dietary restriction (either a standard diet or KD) was tested in another clinically relevant genetic model of Rett syndrome. Rett syndrome is a neurodevelopmental disorder characterized by normal early maturation, followed by a slowing of development, impairment of motor functions, seizure susceptibility, and intellectual disability. In most cases, Rett syndrome is caused by mutations in the methyl-CpG-binding protein 2 (<italic>MECP2</italic>) gene (Amir et al., <xref ref-type="bibr" rid="B4">1999</xref>). Children with Rett syndrome often exhibit autistic-like behaviors in the early stages of the disease (Percy, <xref ref-type="bibr" rid="B139">2011</xref>). Mantis and colleagues found that <italic>Mecp2</italic> mutant mice performed significantly worse in assays of motor function and anxiety compared to wild-type control animals, and restriction of either standard diet or the KD improved motor behavior and reduced anxiety in these mutant animals (Mantis et al., <xref ref-type="bibr" rid="B104">2009</xref>). There is also limited clinical evidence for anti-seizure efficacy and improved behavior after KD treatment in Rett syndrome (Liebhaber et al., <xref ref-type="bibr" rid="B95">2003</xref>).</p>
<p>Most cases of ASD have unknown genetic underpinnings (Gaugler et al., <xref ref-type="bibr" rid="B55">2014</xref>), and models of unidentified etiology have been characterized with behavioral tests assessing autistic symptomatology. The BTBR T+tf/J (BTBR) inbred mouse strain is one of the most clinically relevant animal models of autism; it was identified in an extensive effort to characterize ASD-like behaviors in ten inbred mouse strains (Moy et al., <xref ref-type="bibr" rid="B117">2007</xref>) and displays all the core behavioral features that define the disorder (Moy et al., <xref ref-type="bibr" rid="B117">2007</xref>; McFarlane et al., <xref ref-type="bibr" rid="B114">2008</xref>; Meyza et al., <xref ref-type="bibr" rid="B115">2013</xref>; Ruskin et al., <xref ref-type="bibr" rid="B152">2013</xref>; Smith et al., <xref ref-type="bibr" rid="B158">2014</xref>; Ellegood and Crawley, <xref ref-type="bibr" rid="B43">2015</xref>). BTBR mice display deficits in social interaction and communication assays and exhibit repetitive and stereotyped behaviors. During the relatively short time since its discovery as an ASD model, the BTBR strain has been increasingly used to study the etiology and to uncover potential interventions for ASD (Moy et al., <xref ref-type="bibr" rid="B117">2007</xref>; McFarlane et al., <xref ref-type="bibr" rid="B114">2008</xref>; Llaneza et al., <xref ref-type="bibr" rid="B96">2010</xref>; Ruskin et al., <xref ref-type="bibr" rid="B152">2013</xref>; Cheng et al., <xref ref-type="bibr" rid="B26">2016</xref>; Mychasiuk and Rho, <xref ref-type="bibr" rid="B120">2016</xref>; Newell et al., <xref ref-type="bibr" rid="B128">2016</xref>). Ruskin and colleagues reported that the BTBR mice showed decreased sociability in the three-chamber test, decreased self-directed repetitive behavior, and improved social communication in a food preference assay after being fed a KD (Ruskin et al., <xref ref-type="bibr" rid="B152">2013</xref>). In addition, the authors showed that the behavioral improvements were probably not related to any anti-seizure effect of the diet, because no spontaneous seizures or abnormal EEG features were observed in the BTBR animals.</p>
<p>Interestingly, a recent study showed that gut microbiota composition of cecal and fecal samples was significantly altered in BTBR mice compared to B6 animals (Newell et al., <xref ref-type="bibr" rid="B128">2016</xref>). In addition, a KD decreased total host bacterial abundance in both sample types, and in the BTBR animals counteracted a low Firmicutes to Bacteroidetes ratio, which is commonly observed in patients with ASD (Finegold et al., <xref ref-type="bibr" rid="B46">2010</xref>; De Angelis et al., <xref ref-type="bibr" rid="B35">2013</xref>). Related to these findings, it has been shown that dietary glycemic index, which is a measure of how much the carbohydrate in a food item affects blood glucose level, modulates behavioral and biochemical phenotype in the BTBR mice (Currais et al., <xref ref-type="bibr" rid="B34">2016</xref>). These data support the idea that in the context of genetic predisposition to ASD, diet could potentially alter the expression of the disorders.</p>
<p>More recently, Ruskin et al. also showed KD-induced behavioral improvements in the EL mouse, a model of comorbid ASD-associated behaviors and progressive spontaneous epilepsy. Mice (of both sexes) were fed a KD for 3 weeks after weaning and prior to the age of onset of the seizure phenotype. Sociability improved and repetititve behaviors decreased; intriguingly, these effects were more pronounced in females. Also, some behavioral benefits were observed in females even when a more liberal dietary formulation was applied (Ruskin et al., <xref ref-type="bibr" rid="B150">2016</xref>).</p>
<p>As mentioned above, environmental factors also contribute to the risk of developing ASD. In this regard, exposure to exogenous chemicals is best exemplified by VPA use during pregnancy. VPA is a pharmacological anticonvulsant used in humans primarily for the treatment of epilepsy and migraine, and epidemiological studies have shown that use of VPA during pregnancy is associated with an increased risk of ASD in the offspring (Bromley et al., <xref ref-type="bibr" rid="B17">2013</xref>; Christensen et al., <xref ref-type="bibr" rid="B28">2013</xref>). The VPA exposure model is one of the most frequently studied models of autism (Chomiak et al., <xref ref-type="bibr" rid="B27">2013</xref>; Roullet et al., <xref ref-type="bibr" rid="B149">2013</xref>) since it exhibits many similar structural and behavioral features seen in ASD individuals. Ahn and colleagues found that KD treatment recovered part of the play behavior of juvenile rats exposed to VPA prenatally (Ahn et al., <xref ref-type="bibr" rid="B1">2014</xref>). Interestingly, the authors also found that prenatal exposure to VPA altered mitochondrial respiration, and the KD was able to partially restore this. A recent study in VPA-treated mice also found improved social behavior (Castro et al., <xref ref-type="bibr" rid="B19">2016</xref>).</p>
<p>Taken together, there is increasing evidence for the beneficial effects of the KD in different animal models of ASD. However, clear evidence for converging mechanistic links remains hypothetical, and few fundamental mechanistic studies have been conducted to date in either animal models or human ASD tissues. Thus, there is a need for further studies utilizing diverse animal models and incorporating comprehensive behavioral assays to elucidate common molecular pathways in ASD and to validate the positive effects of the KD observed thus far in animal models. Equally important, studies aimed at identifying the mechanisms relevant to such models of ASD are required to optimize treatment, discover novel therapeutic targets, and ultimately provide key insights to the neurobiology of ASD. Borrowing from the rich literature on the KD in epilepsy, shifts in energy metabolism, the direct actions of the ketone bodies on the mitochondria, neuromodulatory functions of ATP and adenosine, regulation of excitation/inhibition balance, and epigenetic effects of the diet are among the promising candidate mechanisms.</p>
</sec>
<sec id="s6">
<title>Future directions: metabolic therapy and ASD</title>
<p>At present, there is strong evidence that mitochondrial and metabolic dysfunction may underlie the complex pathophysiology of ASD. Precise mechanisms remain elusive and many questions remain unanswered: Is mitochondrial dysfunction a cause or a consequence of ASD? In which specific organs and cell types is it most relevant? Can addressing mitochondrial and metabolic disturbances directly help at least a subgroup of patients with ASD for more targeted treatments that will ameliorate the diverse symptom complex? Thus far, the KD is a proven metabolic therapy for medically intractable epilepsy, but there are only limited data for its use in ASD and a rudimentary understanding of how the KD may exert positive behavioral effects. The optimum formulation of the KD needs to be established and may be different for ASD compared to epilepsy. Proper efforts to address these fundamental questions and to identify molecular mechanisms and biomarkers will require the collective and collaborative efforts of many, including basic, translational and clinical researchers, as well as investigators with diverse expertise in multi-organ dysfunction, metabolism, and genetic and environmental risk factors. The ultimate reward could be a major breakthrough in understanding its causes and developing much-needed broadly effective therapies for ASD—and in particular, treatments that address core symptoms.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>All authors have drafted and revised the manuscript together and approved it for publication.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>This work is supported by Alberta Children's Hospital Research Foundation grant to JR, and NIH grant NS066392 to SM.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>Y.</given-names></name><name><surname>Narous</surname><given-names>M.</given-names></name><name><surname>Tobias</surname><given-names>R.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Mychasiuk</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder</article-title>. <source/>Dev. Neurosci.
<volume>36</volume>, <fpage>371</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1159/000362645</pub-id><pub-id pub-id-type="pmid">25011527</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahola-Erkkila</surname><given-names>S.</given-names></name><name><surname>Carroll</surname><given-names>C. J.</given-names></name><name><surname>Peltola-Mjosund</surname><given-names>K.</given-names></name><name><surname>Tulkki</surname><given-names>V.</given-names></name><name><surname>Mattila</surname><given-names>I.</given-names></name><name><surname>Seppanen-Laakso</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Ketogenic diet slows down mitochondrial myopathy progression in mice</article-title>. <source/>Hum. Mol. Genet.
<volume>19</volume>, <fpage>1974</fpage>–<lpage>1984</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq076</pub-id><pub-id pub-id-type="pmid">20167576</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mosalem</surname><given-names>O. A.</given-names></name><name><surname>El-Ansary</surname><given-names>A.</given-names></name><name><surname>Attas</surname><given-names>O.</given-names></name><name><surname>Al-Ayadhi</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Metabolic biomarkers related to energy metabolism in Saudi autistic children</article-title>. <source/>Clin. Biochem.
<volume>42</volume>, <fpage>949</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2009.04.006</pub-id><pub-id pub-id-type="pmid">19376103</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoedo</surname><given-names>N. D.</given-names></name><name><surname>Punzi</surname><given-names>G.</given-names></name><name><surname>Obre</surname><given-names>E.</given-names></name><name><surname>Lacombe</surname><given-names>D.</given-names></name><name><surname>De Grassi</surname><given-names>A.</given-names></name><name><surname>Pierri</surname><given-names>C. L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>AGC1/2, the mitochondrial aspartate-glutamate carriers</article-title>. <source/>Biochim. Biophys. Acta
<volume>1863</volume>, <fpage>2394</fpage>–<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.04.011</pub-id><pub-id pub-id-type="pmid">27132995</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antico Arciuch</surname><given-names>V. G.</given-names></name><name><surname>Elguero</surname><given-names>M. E.</given-names></name><name><surname>Poderoso</surname><given-names>J. J.</given-names></name><name><surname>Carreras</surname><given-names>M. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial regulation of cell cycle and proliferation</article-title>. <source/>Antioxid. Redox Signal.
<volume>16</volume>, <fpage>1150</fpage>–<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4085</pub-id><pub-id pub-id-type="pmid">21967640</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>E.</given-names></name><name><surname>Jeste</surname><given-names>S. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Diagnosis and management of autism spectrum disorder in the era of genomics: rare disorders can pave the way for targeted treatments</article-title>. <source/>Pediatr. Clin. North Am.
<volume>62</volume>, <fpage>607</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcl.2015.03.003</pub-id><pub-id pub-id-type="pmid">26022165</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balietti</surname><given-names>M.</given-names></name><name><surname>Fattoretti</surname><given-names>P.</given-names></name><name><surname>Giorgetti</surname><given-names>B.</given-names></name><name><surname>Casoli</surname><given-names>T.</given-names></name><name><surname>Di Stefano</surname><given-names>G.</given-names></name><name><surname>Platano</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Effect of two medium chain triglycerides-supplemented diets on synaptic morphology in the cerebellar cortex of late-adult rats</article-title>. <source/>Microsc. Res. Tech.
<volume>72</volume>, <fpage>933</fpage>–<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1002/jemt.20737</pub-id><pub-id pub-id-type="pmid">19455680</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balietti</surname><given-names>M.</given-names></name><name><surname>Giorgetti</surname><given-names>B.</given-names></name><name><surname>Fattoretti</surname><given-names>P.</given-names></name><name><surname>Grossi</surname><given-names>Y.</given-names></name><name><surname>Di Stefano</surname><given-names>G.</given-names></name><name><surname>Casoli</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Ketogenic diets cause opposing changes in synaptic morphology in CA1 hippocampus and dentate gyrus of late-adult rats</article-title>. <source/>Rejuvenation Res.
<volume>11</volume>, <fpage>631</fpage>–<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2007.0650</pub-id><pub-id pub-id-type="pmid">18593281</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>J. M.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Autism genetics: searching for specificity and convergence</article-title>. <source/>Genome Biol.
<volume>13</volume>:<fpage>247</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2012-13-7-247</pub-id><pub-id pub-id-type="pmid">22849751</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhandari</surname><given-names>R.</given-names></name><name><surname>Kuhad</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders</article-title>. <source/>Life Sci.
<volume>141</volume>, <fpage>156</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2015.09.012</pub-id><pub-id pub-id-type="pmid">26407474</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccuto</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>C.-F.</given-names></name><name><surname>Pittman</surname><given-names>A. R.</given-names></name><name><surname>Skinner</surname><given-names>C. D.</given-names></name><name><surname>McCartney</surname><given-names>H. J.</given-names></name><name><surname>Jones</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Decreased tryptophan metabolism in patients with autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>4</volume>:<fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-16</pub-id><pub-id pub-id-type="pmid">23731516</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boison</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>The biochemistry and epigenetics of epilepsy: focus on adenosine and glycine</article-title>. <source/>Front. Mol. Neurosci.
<volume>9</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2016.00026</pub-id><pub-id pub-id-type="pmid">27147960</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bough</surname><given-names>K. J.</given-names></name><name><surname>Wetherington</surname><given-names>J.</given-names></name><name><surname>Hassel</surname><given-names>B.</given-names></name><name><surname>Pare</surname><given-names>J. F.</given-names></name><name><surname>Gawryluk</surname><given-names>J. W.</given-names></name><name><surname>Greene</surname><given-names>J. G.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet</article-title>. <source/>Ann. Neurol.
<volume>60</volume>, <fpage>223</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20899</pub-id><pub-id pub-id-type="pmid">16807920</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgeron</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>. <source/>Nat. Rev. Neurosci.
<volume>16</volume>, <fpage>551</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3992</pub-id><pub-id pub-id-type="pmid">26289574</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname><given-names>J.</given-names></name></person-group> (<year>1983</year>). <article-title>Carnitine–metabolism and functions</article-title>. <source/>Physiol. Rev.
<volume>63</volume>, <fpage>1420</fpage>–<lpage>1480</lpage>. <pub-id pub-id-type="pmid">6361812</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bromley</surname><given-names>R. L.</given-names></name><name><surname>Mawer</surname><given-names>G. E.</given-names></name><name><surname>Briggs</surname><given-names>M.</given-names></name><name><surname>Cheyne</surname><given-names>C.</given-names></name><name><surname>Clayton-Smith</surname><given-names>J.</given-names></name><name><surname>Garcia-Finana</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs</article-title>. <source/>J. Neurol. Neurosurg. Psychiatr.
<volume>84</volume>, <fpage>637</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-304270</pub-id><pub-id pub-id-type="pmid">23370617</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buescher</surname><given-names>A. V.</given-names></name><name><surname>Cidav</surname><given-names>Z.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Mandell</surname><given-names>D. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Costs of autism spectrum disorders in the United Kingdom and the United States</article-title>. <source/>JAMA Pediatr.
<volume>168</volume>, <fpage>721</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2014.210</pub-id><pub-id pub-id-type="pmid">24911948</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>K.</given-names></name><name><surname>Baronio</surname><given-names>D.</given-names></name><name><surname>Perry</surname><given-names>I. S.</given-names></name><name><surname>dos Santos Riesgo</surname><given-names>R.</given-names></name><name><surname>Gottfried</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid</article-title>. <source/>Nutr. Neurosci. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1080/1028415X.2015.1133029</pub-id><pub-id pub-id-type="pmid">26856821</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>CDC</collab></person-group> (<year>2014</year>). <article-title>Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010</article-title>. <source/>Morb. Mort. Wkly Rep. Surveil. Summ.
<volume>63</volume>, <fpage>1</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celestino-Soper</surname><given-names>P. B. S.</given-names></name><name><surname>Violante</surname><given-names>S.</given-names></name><name><surname>Crawford</surname><given-names>E. L.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Delaby</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>109</volume>, <fpage>7974</fpage>–<lpage>7981</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1120210109</pub-id><pub-id pub-id-type="pmid">22566635</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaidez</surname><given-names>V.</given-names></name><name><surname>Hansen</surname><given-names>R. L.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Gastrointestinal problems in children with autism, developmental delays or typical development</article-title>. <source/>J. Autism Dev. Disord.
<volume>44</volume>, <fpage>1117</fpage>–<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-013-1973-x</pub-id><pub-id pub-id-type="pmid">24193577</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>P.</given-names></name><name><surname>Augustin</surname><given-names>K.</given-names></name><name><surname>Boddum</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Terschak</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Seizure control by decanoic acid through direct AMPA receptor inhibition</article-title>. <source/>Brain
<volume>139</volume>(<issue>Pt 2</issue>), <fpage>431</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv325</pub-id><pub-id pub-id-type="pmid">26608744</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Autism risk factors: genes, environment, and gene-environment interactions</article-title>. <source/>Dialogues Clin. Neurosci.
<volume>14</volume>, <fpage>281</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="pmid">23226953</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism</article-title>. <source/>BMC Psychiatry
<volume>15</volume>:<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-015-0432-y</pub-id><pub-id pub-id-type="pmid">25884388</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>N.</given-names></name><name><surname>Khanbabaei</surname><given-names>M.</given-names></name><name><surname>Murari</surname><given-names>K.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Disruption of visual circuit formation and refinement in a mouse model of autism</article-title>. <source/>Autism Res. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1002/aur.1687</pub-id><pub-id pub-id-type="pmid">27529416</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomiak</surname><given-names>T.</given-names></name><name><surname>Turner</surname><given-names>N.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>What we have learned about autism spectrum disorder from valproic acid</article-title>. <source/>Patholog. Res. Int.
<volume>2013</volume>:<fpage>712758</fpage>. <pub-id pub-id-type="doi">10.1155/2013/712758</pub-id><pub-id pub-id-type="pmid">24381784</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Gronborg</surname><given-names>T. K.</given-names></name><name><surname>Sorensen</surname><given-names>M. J.</given-names></name><name><surname>Schendel</surname><given-names>D.</given-names></name><name><surname>Parner</surname><given-names>E. T.</given-names></name><name><surname>Pedersen</surname><given-names>L. H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism</article-title>. <source/>JAMA
<volume>309</volume>, <fpage>1696</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2013.2270</pub-id><pub-id pub-id-type="pmid">23613074</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciarlone</surname><given-names>S. L.</given-names></name><name><surname>Grieco</surname><given-names>J. C.</given-names></name><name><surname>D'Agostino</surname><given-names>D. P.</given-names></name><name><surname>Weeber</surname><given-names>E. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model</article-title>. <source/>Neurobiol. Dis.
<volume>96</volume>, <fpage>38</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.08.002</pub-id><pub-id pub-id-type="pmid">27546058</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>D. J.</given-names></name><name><surname>Johnson</surname><given-names>W.</given-names></name><name><surname>Caparulo</surname><given-names>B. K.</given-names></name><name><surname>Young</surname><given-names>J. G.</given-names></name></person-group> (<year>1976</year>). <article-title>Creatine phosphokinase levels in children with severe developmental disturbances</article-title>. <source/>Arch. Gen. Psychiatry
<volume>33</volume>, <fpage>683</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1976.01770060025004</pub-id><pub-id pub-id-type="pmid">59582</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>C.</given-names></name><name><surname>Coutinho</surname><given-names>A. M.</given-names></name><name><surname>Diogo</surname><given-names>L.</given-names></name><name><surname>Grazina</surname><given-names>M.</given-names></name><name><surname>Marques</surname><given-names>C.</given-names></name><name><surname>Miguel</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Brief report: high frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier <italic>SLC25A12</italic> gene</article-title>. <source/>J. Autism Dev. Disord.
<volume>36</volume>, <fpage>1137</fpage>–<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-006-0138-6</pub-id><pub-id pub-id-type="pmid">17151801</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Pierce</surname><given-names>K.</given-names></name><name><surname>Schumann</surname><given-names>C. M.</given-names></name><name><surname>Redcay</surname><given-names>E.</given-names></name><name><surname>Buckwalter</surname><given-names>J. A.</given-names></name><name><surname>Kennedy</surname><given-names>D. P.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Mapping early brain development in autism</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>399</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.016</pub-id><pub-id pub-id-type="pmid">17964254</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullingford</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Peroxisome proliferator-activated receptor alpha and the ketogenic diet</article-title>. <source/>Epilepsia
<volume>49</volume>(<issue>Suppl. 8</issue>), <fpage>70</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01840.x</pub-id><pub-id pub-id-type="pmid">19049593</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currais</surname><given-names>A.</given-names></name><name><surname>Farrokhi</surname><given-names>C.</given-names></name><name><surname>Dargusch</surname><given-names>R.</given-names></name><name><surname>Goujon-Svrzic</surname><given-names>M.</given-names></name><name><surname>Maher</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>426</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.64</pub-id><pub-id pub-id-type="pmid">26055422</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Piccolo</surname><given-names>M.</given-names></name><name><surname>Vannini</surname><given-names>L.</given-names></name><name><surname>Siragusa</surname><given-names>S.</given-names></name><name><surname>De Giacomo</surname><given-names>A.</given-names></name><name><surname>Serrazzanetti</surname><given-names>D. I.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e76993</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0076993</pub-id><pub-id pub-id-type="pmid">24130822</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Filippis</surname><given-names>B.</given-names></name><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>de Bari</surname><given-names>L.</given-names></name><name><surname>De Rasmo</surname><given-names>D.</given-names></name><name><surname>Musto</surname><given-names>M.</given-names></name><name><surname>Fabbri</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1</article-title>. <source/>Free Radic. Biol. Med.
<volume>83</volume>, <fpage>167</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.02.014</pub-id><pub-id pub-id-type="pmid">25708779</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre-Ubieta</surname><given-names>L.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>J. L.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title>. <source/>Nat. Med.
<volume>22</volume>, <fpage>345</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4071</pub-id><pub-id pub-id-type="pmid">27050589</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetics and genomics of autism spectrum disorder: embracing complexity</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>R24</fpage>–<lpage>R31</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv273</pub-id><pub-id pub-id-type="pmid">26188008</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Genetic architecture in autism spectrum disorder</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>22</volume>, <fpage>229</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2012.03.002</pub-id><pub-id pub-id-type="pmid">22463983</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>S.</given-names></name><name><surname>Hellings</surname><given-names>J. A.</given-names></name><name><surname>Butler</surname><given-names>M. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetics and mitochondrial abnormalities in autism spectrum disorders: a review</article-title>. <source/>Curr. Genomics
<volume>12</volume>, <fpage>322</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.2174/138920211796429745</pub-id><pub-id pub-id-type="pmid">22294875</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiCicco-Bloom</surname><given-names>E.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L.</given-names></name><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Dager</surname><given-names>S. R.</given-names></name><name><surname>Schmitz</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>The developmental neurobiology of autism spectrum disorder</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>6897</fpage>–<lpage>6906</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1712-06.2006</pub-id><pub-id pub-id-type="pmid">16807320</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durkin</surname><given-names>M. S.</given-names></name><name><surname>Maenner</surname><given-names>M. J.</given-names></name><name><surname>Newschaffer</surname><given-names>C. J.</given-names></name><name><surname>Lee</surname><given-names>L. C.</given-names></name><name><surname>Cunniff</surname><given-names>C. M.</given-names></name><name><surname>Daniels</surname><given-names>J. L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Advanced parental age and the risk of autism spectrum disorder</article-title>. <source/>Am. J. Epidemiol.
<volume>168</volume>, <fpage>1268</fpage>–<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwn250</pub-id><pub-id pub-id-type="pmid">18945690</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellegood</surname><given-names>J.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Behavioral and neuroanatomical phenotypes in mouse models of autism</article-title>. <source/>Neurotherapeutics
<volume>12</volume>, <fpage>521</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-015-0360-z</pub-id><pub-id pub-id-type="pmid">26036957</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangeliou</surname><given-names>A.</given-names></name><name><surname>Vlachonikolis</surname><given-names>I.</given-names></name><name><surname>Mihailidou</surname><given-names>H.</given-names></name><name><surname>Spilioti</surname><given-names>M.</given-names></name><name><surname>Skarpalezou</surname><given-names>A.</given-names></name><name><surname>Makaronas</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Application of a ketogenic diet in children with autistic behavior: pilot study</article-title>. <source/>J. Child Neurol.
<volume>18</volume>, <fpage>113</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1177/08830738030180020501</pub-id><pub-id pub-id-type="pmid">12693778</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipek</surname><given-names>P. A.</given-names></name><name><surname>Juranek</surname><given-names>J.</given-names></name><name><surname>Nguyen</surname><given-names>M. T.</given-names></name><name><surname>Cummings</surname><given-names>C.</given-names></name><name><surname>Gargus</surname><given-names>J. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Relative carnitine deficiency in autism</article-title>. <source/>J. Autism Dev. Disord.
<volume>34</volume>, <fpage>615</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-004-5283-1</pub-id><pub-id pub-id-type="pmid">15679182</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>S. M.</given-names></name><name><surname>Dowd</surname><given-names>S. E.</given-names></name><name><surname>Gontcharova</surname><given-names>V.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Henley</surname><given-names>K. E.</given-names></name><name><surname>Wolcott</surname><given-names>R. D.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>. <source/>Anaerobe
<volume>16</volume>, <fpage>444</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.06.008</pub-id><pub-id pub-id-type="pmid">20603222</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder</article-title>. <source/>Epilepsy Behav.
<volume>47</volume>, <fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2014.08.134</pub-id><pub-id pub-id-type="pmid">25440829</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Melnyk</surname><given-names>S.</given-names></name><name><surname>Macfabe</surname><given-names>D. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder</article-title>. <source/>Transl. Psychiatry
<volume>3</volume>:<fpage>e220</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2012.143</pub-id><pub-id pub-id-type="pmid">23340503</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Slattery</surname><given-names>J.</given-names></name><name><surname>MacFabe</surname><given-names>D. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome</article-title>. <source/>Microb. Ecol. Health Dis.
<volume>26</volume>:<fpage>27458</fpage>. <pub-id pub-id-type="doi">10.3402/mehd.v26.27458</pub-id><pub-id pub-id-type="pmid">25956238</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Rossignol</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders</article-title>. <source/>Pediatric Res.
<volume>69</volume>(5 Pt 2), <fpage>41R</fpage>–<lpage>47R</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e318212f16b</pub-id><pub-id pub-id-type="pmid">21289536</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Rossignol</surname><given-names>D. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes</article-title>. <source/>Clin. Med. Insights Pediatrics
<volume>10</volume>, <fpage>43</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.4137/CMPed.S38337</pub-id><pub-id pub-id-type="pmid">27330338</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gano</surname><given-names>L. B.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Ketogenic diets, mitochondria, and neurological diseases</article-title>. <source/>J. Lipid Res.
<volume>55</volume>, <fpage>2211</fpage>–<lpage>2228</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.R048975</pub-id><pub-id pub-id-type="pmid">24847102</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardener</surname><given-names>H.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Buka</surname><given-names>S. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis</article-title>. <source/>Pediatrics
<volume>128</volume>, <fpage>344</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2010-1036</pub-id><pub-id pub-id-type="pmid">21746727</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garriga-Canut</surname><given-names>M.</given-names></name><name><surname>Schoenike</surname><given-names>B.</given-names></name><name><surname>Qazi</surname><given-names>R.</given-names></name><name><surname>Bergendahl</surname><given-names>K.</given-names></name><name><surname>Daley</surname><given-names>T. J.</given-names></name><name><surname>Pfender</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure</article-title>. <source/>Nat. Neurosci.
<volume>9</volume>, <fpage>1382</fpage>–<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1038/nn1791</pub-id><pub-id pub-id-type="pmid">17041593</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaugler</surname><given-names>T.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Bodea</surname><given-names>C. A.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Lee</surname><given-names>A. B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Most genetic risk for autism resides with common variation</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>881</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3039</pub-id><pub-id pub-id-type="pmid">25038753</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Autism: many genes, common pathways?</article-title>
<source/>Cell
<volume>135</volume>, <fpage>391</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.10.016</pub-id><pub-id pub-id-type="pmid">18984147</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Cai</surname><given-names>G.</given-names></name><name><surname>Korvatska</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>C. E.</given-names></name><name><surname>Wood</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes</article-title>. <source/>Nature
<volume>459</volume>, <fpage>569</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1038/nature07953</pub-id><pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>DiMauro</surname><given-names>S.</given-names></name><name><surname>Peterson</surname><given-names>B. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging</article-title>. <source/>JAMA Psychiatry
<volume>71</volume>, <fpage>665</fpage>–<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.179</pub-id><pub-id pub-id-type="pmid">24718932</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goines</surname><given-names>P.</given-names></name><name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The immune system's role in the biology of autism</article-title>. <source/>Curr. Opin. Neurol.
<volume>23</volume>, <fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e3283373514</pub-id><pub-id pub-id-type="pmid">20160651</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>R. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Autism and mitochondrial disease</article-title>. <source/>Dev. Disabil. Res. Rev.
<volume>16</volume>, <fpage>144</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1002/ddrr.112</pub-id><pub-id pub-id-type="pmid">20818729</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>S. N.</given-names></name><name><surname>Schendel</surname><given-names>D. E.</given-names></name><name><surname>Parner</surname><given-names>E. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices</article-title>. <source/>JAMA Pediatr.
<volume>169</volume>, <fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2014.1893</pub-id><pub-id pub-id-type="pmid">25365033</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J. J.</given-names></name><name><surname>Jolivet</surname><given-names>R.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Synaptic energy use and supply</article-title>. <source/>Neuron
<volume>75</volume>, <fpage>762</fpage>–<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.019</pub-id><pub-id pub-id-type="pmid">22958818</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>M. R.</given-names></name><name><surname>Buckley</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism and dietary therapy: case report and review of the literature</article-title>. <source/>J. Child Neurol.
<volume>28</volume>, <fpage>975</fpage>–<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1177/0883073813488668</pub-id><pub-id pub-id-type="pmid">23666039</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrynevich</surname><given-names>S. V.</given-names></name><name><surname>Waseem</surname><given-names>T. V.</given-names></name><name><surname>Hebert</surname><given-names>A.</given-names></name><name><surname>Pellerin</surname><given-names>L.</given-names></name><name><surname>Fedorovich</surname><given-names>S. V.</given-names></name></person-group> (<year>2016</year>). <article-title>β-Hydroxybutyrate supports synaptic vesicle cycling but reduces endocytosis and exocytosis in rat brain synaptosomes</article-title>. <source/>Neurochem. Int.
<volume>93</volume>, <fpage>73</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.12.014</pub-id><pub-id pub-id-type="pmid">26748385</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>E. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Immune dysregulation in autism spectrum disorder</article-title>. <source/>Int. Rev. Neurobiol.
<volume>113</volume>, <fpage>269</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-418700-9.00009-5</pub-id><pub-id pub-id-type="pmid">24290389</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huguet</surname><given-names>G.</given-names></name><name><surname>Ey</surname><given-names>E.</given-names></name><name><surname>Bourgeron</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>The genetic landscapes of autism spectrum disorders</article-title>. <source/>Annu. Rev. Genomics Hum. Genet.
<volume>14</volume>, <fpage>191</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genom-091212-153431</pub-id><pub-id pub-id-type="pmid">23875794</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hullinger</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Dowell</surname><given-names>J. A.</given-names></name><name><surname>Bomba-Warczak</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Increased expression of AT-1/SLC33A1 causes an autistic-like phenotype in mice by affecting dendritic branching and spine formation</article-title>. <source/>J. Exp. Med.
<volume>213</volume>, <fpage>1267</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151776</pub-id><pub-id pub-id-type="pmid">27242167</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>IJff</surname><given-names>D. M.</given-names></name><name><surname>Postulart</surname><given-names>D.</given-names></name><name><surname>Lambrechts</surname><given-names>D. A.</given-names></name><name><surname>Majoie</surname><given-names>M. H.</given-names></name><name><surname>de Kinderen</surname><given-names>R. J.</given-names></name><name><surname>Hendriksen</surname><given-names>J. G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: a randomized controlled trial</article-title>. <source/>Epilepsy Behav.
<volume>60</volume>, <fpage>153</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.04.033</pub-id><pub-id pub-id-type="pmid">27206235</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inan</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Manuszak</surname><given-names>M.</given-names></name><name><surname>Karakaya</surname><given-names>C.</given-names></name><name><surname>Rajadhyaksha</surname><given-names>A. M.</given-names></name><name><surname>Pickel</surname><given-names>V. M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability</article-title>. <source/>Neurobiol. Dis.
<volume>93</volume>, <fpage>35</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.04.004</pub-id><pub-id pub-id-type="pmid">27105708</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>E. A.</given-names></name><name><surname>Jeon</surname><given-names>B. T.</given-names></name><name><surname>Shin</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>D. H.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures</article-title>. <source/>Exp. Neurol.
<volume>232</volume>, <fpage>195</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.09.001</pub-id><pub-id pub-id-type="pmid">21939657</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeste</surname><given-names>S. S.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Disentangling the heterogeneity of autism spectrum disorder through genetic findings</article-title>. <source/>Nat. Rev. Neurol.
<volume>10</volume>, <fpage>74</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2013.278</pub-id><pub-id pub-id-type="pmid">24468882</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L.-W.</given-names></name><name><surname>Horiuchi</surname><given-names>M.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.-B.</given-names></name><name><surname>Cortopassi</surname><given-names>G. A.</given-names></name><name><surname>Erickson</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>2516</fpage>–<lpage>2529</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2778-14.2015</pub-id><pub-id pub-id-type="pmid">25673846</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juge</surname><given-names>N.</given-names></name><name><surname>Gray</surname><given-names>J. A.</given-names></name><name><surname>Omote</surname><given-names>H.</given-names></name><name><surname>Miyaji</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Metabolic control of vesicular glutamate transport and release</article-title>. <source/>Neuron
<volume>68</volume>, <fpage>99</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.002</pub-id><pub-id pub-id-type="pmid">20920794</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kann</surname><given-names>O.</given-names></name><name><surname>Kovacs</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Mitochondria and neuronal activity</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>292</volume>, <fpage>C641</fpage>–<lpage>C657</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00222.2006</pub-id><pub-id pub-id-type="pmid">17092996</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>L.</given-names></name><name><surname>Lambert</surname><given-names>C.</given-names></name><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Elliott</surname><given-names>H.</given-names></name><name><surname>Wheelwright</surname><given-names>S.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>The mitochondrial DNA A3243A&gt;G mutation must be an infrequent cause of Asperger syndrome</article-title>. <source/>J. Pediatr.
<volume>149</volume>, <fpage>280</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2005.08.060</pub-id><pub-id pub-id-type="pmid">16887455</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>G.</given-names></name><name><surname>Motokawa</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Hiraga</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia</article-title>. <source/>Proc. Jpn Acad. B Phys. Biol. Sci.
<volume>84</volume>, <fpage>246</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.2183/pjab.84.246</pub-id><pub-id pub-id-type="pmid">18941301</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. J.</given-names></name><name><surname>Silva</surname><given-names>R. M.</given-names></name><name><surname>Flores</surname><given-names>C. G.</given-names></name><name><surname>Jacob</surname><given-names>S.</given-names></name><name><surname>Guter</surname><given-names>S.</given-names></name><name><surname>Valcante</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>A quantitative association study of SLC25A12 and restricted repetitive behavior traits in autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>2</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-2-8</pub-id><pub-id pub-id-type="pmid">21609426</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Leventhal</surname><given-names>B. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders</article-title>. <source/>Biol. Psychiatry
<volume>77</volume>, <fpage>66</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.001</pub-id><pub-id pub-id-type="pmid">25483344</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim do</surname><given-names>Y.</given-names></name><name><surname>Davis</surname><given-names>L. M.</given-names></name><name><surname>Sullivan</surname><given-names>P. G.</given-names></name><name><surname>Maalouf</surname><given-names>M.</given-names></name><name><surname>Simeone</surname><given-names>T. A.</given-names></name><name><surname>van Brederode</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Ketone bodies are protective against oxidative stress in neocortical neurons</article-title>. <source/>J. Neurochem.
<volume>101</volume>, <fpage>1316</fpage>–<lpage>1326</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04483.x</pub-id><pub-id pub-id-type="pmid">17403035</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim do</surname><given-names>Y.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2008</year>). <article-title>The ketogenic diet and epilepsy</article-title>. <source/>Curr. Opin. Clin. Nutr. Metab. Care
<volume>11</volume>, <fpage>113</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0b013e3282f44c06</pub-id><pub-id pub-id-type="pmid">18301085</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim do</surname><given-names>Y.</given-names></name><name><surname>Simeone</surname><given-names>K. A.</given-names></name><name><surname>Simeone</surname><given-names>T. A.</given-names></name><name><surname>Pandya</surname><given-names>J. D.</given-names></name><name><surname>Wilke</surname><given-names>J. C.</given-names></name><name><surname>Ahn</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Ketone bodies mediate antiseizure effects through mitochondrial permeability transition</article-title>. <source/>Ann. Neurol.
<volume>78</volume>, <fpage>77</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24424</pub-id><pub-id pub-id-type="pmid">25899847</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Murakami</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Evidence that dendritic mitochondria negatively regulate dendritic branching in pyramidal neurons in the neocortex</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>6938</fpage>–<lpage>6951</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5095-13.2014</pub-id><pub-id pub-id-type="pmid">24828647</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinman</surname><given-names>J. M.</given-names></name><name><surname>Ventola</surname><given-names>P. E.</given-names></name><name><surname>Pandey</surname><given-names>J.</given-names></name><name><surname>Verbalis</surname><given-names>A. D.</given-names></name><name><surname>Barton</surname><given-names>M.</given-names></name><name><surname>Hodgson</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Diagnostic stability in very young children with autism spectrum disorders</article-title>. <source/>J. Autism Dev. Disord.
<volume>38</volume>, <fpage>606</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-007-0427-8</pub-id><pub-id pub-id-type="pmid">17924183</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohane</surname><given-names>I. S.</given-names></name><name><surname>McMurry</surname><given-names>A.</given-names></name><name><surname>Weber</surname><given-names>G.</given-names></name><name><surname>MacFadden</surname><given-names>D.</given-names></name><name><surname>Rappaport</surname><given-names>L.</given-names></name><name><surname>Kunkel</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The co-morbidity burden of children and young adults with autism spectrum disorders</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e33224</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033224</pub-id><pub-id pub-id-type="pmid">22511918</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>N.</given-names></name><name><surname>Climer</surname><given-names>S.</given-names></name><name><surname>Dougherty</surname><given-names>J. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Moving from capstones toward cornerstones: successes and challenges in applying systems biology to identify mechanisms of autism spectrum disorders</article-title>. <source/>Front. Genet.
<volume>6</volume>:<fpage>301</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2015.00301</pub-id><pub-id pub-id-type="pmid">26500678</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakowiak</surname><given-names>P.</given-names></name><name><surname>Walker</surname><given-names>C. K.</given-names></name><name><surname>Bremer</surname><given-names>A. A.</given-names></name><name><surname>Baker</surname><given-names>A. S.</given-names></name><name><surname>Ozonoff</surname><given-names>S.</given-names></name><name><surname>Hansen</surname><given-names>R. L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders</article-title>. <source/>Pediatrics
<volume>129</volume>, <fpage>e1121</fpage>–<lpage>e1128</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2011-2583</pub-id><pub-id pub-id-type="pmid">22492772</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriaucionis</surname><given-names>S.</given-names></name><name><surname>Paterson</surname><given-names>A.</given-names></name><name><surname>Curtis</surname><given-names>J.</given-names></name><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Macleod</surname><given-names>N.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome</article-title>. <source/>Mol. Cell. Biol.
<volume>26</volume>, <fpage>5033</fpage>–<lpage>5042</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.01665-05</pub-id><pub-id pub-id-type="pmid">16782889</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>H.</given-names></name><name><surname>Sharma</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Memantine ameliorates autistic behavior, biochemistry &amp; blood brain barrier impairments in rats</article-title>. <source/>Brain Res. Bull.
<volume>124</volume>, <fpage>27</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2016.03.013</pub-id><pub-id pub-id-type="pmid">27034117</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwabara</surname><given-names>H.</given-names></name><name><surname>Yamasue</surname><given-names>H.</given-names></name><name><surname>Koike</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Kawakubo</surname><given-names>Y.</given-names></name><name><surname>Kuroda</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e73814</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0073814</pub-id><pub-id pub-id-type="pmid">24058493</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>M. C.</given-names></name><name><surname>Lombardo</surname><given-names>M. V.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism</article-title>. <source/>Lancet
<volume>383</volume>, <fpage>896</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id><pub-id pub-id-type="pmid">24074734</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>László</surname><given-names>A.</given-names></name><name><surname>Horváth</surname><given-names>E.</given-names></name><name><surname>Eck</surname><given-names>E.</given-names></name><name><surname>Fekete</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Serum serotonin, lactate and pyruvate levels in infantile autistic children</article-title>. <source/>Clin. Chim. Acta
<volume>229</volume>, <fpage>205</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/0009-8981(94)90243-7</pub-id><pub-id pub-id-type="pmid">7988051</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legido</surname><given-names>A.</given-names></name><name><surname>Jethva</surname><given-names>R.</given-names></name><name><surname>Goldenthal</surname><given-names>M. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial dysfunction in autism</article-title>. <source/>Semin. Pediatr. Neurol.
<volume>20</volume>, <fpage>163</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.spen.2013.10.008</pub-id><pub-id pub-id-type="pmid">24331358</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>S. E.</given-names></name><name><surname>Giarelli</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>L. C.</given-names></name><name><surname>Schieve</surname><given-names>L. A.</given-names></name><name><surname>Kirby</surname><given-names>R. S.</given-names></name><name><surname>Cunniff</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States</article-title>. <source/>J. Dev. Behav. Pediatr.
<volume>31</volume>, <fpage>267</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1097/DBP.0b013e3181d5d03b</pub-id><pub-id pub-id-type="pmid">20431403</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses</article-title>. <source/>Cell
<volume>119</volume>, <fpage>873</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.11.003</pub-id><pub-id pub-id-type="pmid">15607982</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebhaber</surname><given-names>G. M.</given-names></name><name><surname>Riemann</surname><given-names>E.</given-names></name><name><surname>Baumeister</surname><given-names>F. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Ketogenic diet in Rett syndrome</article-title>. <source/>J. Child Neurol.
<volume>18</volume>, <fpage>74</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1177/08830738030180011801</pub-id><pub-id pub-id-type="pmid">12661945</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llaneza</surname><given-names>D. C.</given-names></name><name><surname>DeLuke</surname><given-names>S. V.</given-names></name><name><surname>Batista</surname><given-names>M.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name><name><surname>Christodulu</surname><given-names>K. V.</given-names></name><name><surname>Frye</surname><given-names>C. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Communication, interventions, and scientific advances in autism: a commentary</article-title>. <source/>Physiol. Behav.
<volume>100</volume>, <fpage>268</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2010.01.003</pub-id><pub-id pub-id-type="pmid">20093134</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loke</surname><given-names>Y. J.</given-names></name><name><surname>Hannan</surname><given-names>A. J.</given-names></name><name><surname>Craig</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of epigenetic change in autism spectrum disorders</article-title>. <source/>Front. Neurol.
<volume>6</volume>:<fpage>107</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2015.00107</pub-id><pub-id pub-id-type="pmid">26074864</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Risi</surname><given-names>S.</given-names></name><name><surname>DiLavore</surname><given-names>P. S.</given-names></name><name><surname>Shulman</surname><given-names>C.</given-names></name><name><surname>Thurm</surname><given-names>A.</given-names></name><name><surname>Pickles</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Autism from 2 to 9 years of age</article-title>. <source/>Arch. Gen. Psychiatry
<volume>63</volume>, <fpage>694</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.6.694</pub-id><pub-id pub-id-type="pmid">16754843</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutas</surname><given-names>A.</given-names></name><name><surname>Yellen</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>The ketogenic diet: metabolic influences on brain excitability and epilepsy</article-title>. <source/>Trends Neurosci.
<volume>36</volume>, <fpage>32</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.11.005</pub-id><pub-id pub-id-type="pmid">23228828</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maalouf</surname><given-names>M.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2009</year>). <article-title>The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies</article-title>. <source/>Brain Res. Rev.
<volume>59</volume>, <fpage>293</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.09.002</pub-id><pub-id pub-id-type="pmid">18845187</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macfabe</surname><given-names>D. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders</article-title>. <source/>Microb. Ecol. Health Dis.
<volume>23</volume>:<fpage>19260</fpage>. <pub-id pub-id-type="doi">10.3402/mehd.v23i0.19260</pub-id><pub-id pub-id-type="pmid">23990817</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maestrini</surname><given-names>E.</given-names></name><name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name><name><surname>Lamb</surname><given-names>J. A.</given-names></name><name><surname>Bacchelli</surname><given-names>E.</given-names></name><name><surname>Sykes</surname><given-names>N. H.</given-names></name><name><surname>Sousa</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>High-density SNP association study and copy number variation analysis of the <italic>AUTS1</italic> and <italic>AUTS5</italic> loci implicate the <italic>IMMP2L-DOCK4</italic> gene region in autism susceptibility</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>954</fpage>–<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.34</pub-id><pub-id pub-id-type="pmid">19401682</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahfouz</surname><given-names>A.</given-names></name><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Rennert</surname><given-names>O. M.</given-names></name><name><surname>Lelieveldt</surname><given-names>B. P.</given-names></name><name><surname>Reinders</surname><given-names>M. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Shared pathways among autism candidate genes determined by co-expression network analysis of the developing human brain transcriptome</article-title>. <source/>J. Mol. Neurosci.
<volume>57</volume>, <fpage>580</fpage>–<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-015-0641-3</pub-id><pub-id pub-id-type="pmid">26399424</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantis</surname><given-names>J. G.</given-names></name><name><surname>Fritz</surname><given-names>C. L.</given-names></name><name><surname>Marsh</surname><given-names>J.</given-names></name><name><surname>Heinrichs</surname><given-names>S. C.</given-names></name><name><surname>Seyfried</surname><given-names>T. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets</article-title>. <source/>Epilepsy Behav.
<volume>15</volume>, <fpage>133</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2009.02.038</pub-id><pub-id pub-id-type="pmid">19249385</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Geiger</surname><given-names>J. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?</article-title>
<source/>Trends Neurosci.
<volume>31</volume>, <fpage>273</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.02.009</pub-id><pub-id pub-id-type="pmid">18471903</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names><suffix>Jr.</suffix></name><name><surname>Cote</surname><given-names>J. L.</given-names></name><name><surname>Williams</surname><given-names>R. B.</given-names></name><name><surname>Ruskin</surname><given-names>D. N.</given-names></name></person-group> (<year>2013</year>). <article-title>Adenosine and autism: a spectrum of opportunities</article-title>. <source/>Neuropharmacology
<volume>68</volume>, <fpage>116</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.08.013</pub-id><pub-id pub-id-type="pmid">22940000</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names><suffix>Jr.</suffix></name><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Gawryluk</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Geiger</surname><given-names>J. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Purines and the anti-epileptic actions of ketogenic diets</article-title>. <source/>Open Neurosci. J.
<volume>4</volume>, <fpage>58</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.2174/1874082001004010058</pub-id><pub-id pub-id-type="pmid">22064941</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names></name><name><surname>Wasser</surname><given-names>C. D.</given-names></name><name><surname>Pomeroy</surname><given-names>L. T.</given-names></name><name><surname>Ruskin</surname><given-names>D. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity</article-title>. <source/>Curr. Neuropharmacol.
<volume>7</volume>, <fpage>257</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.2174/157015909789152164</pub-id><pub-id pub-id-type="pmid">20190967</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanisms of ketogenic diet action</article-title>, in <source/>Jasper's Basic Mechanisms of the Epilepsies, 4th Edn., eds <person-group person-group-type="editor"><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Avoli</surname><given-names>M.</given-names></name><name><surname>Rogawski</surname><given-names>M. A.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A. V.</given-names></name></person-group> (<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>).</mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Svedova</surname><given-names>J.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names></name><name><surname>DiMario</surname><given-names>F. D.</given-names></name><name><surname>Eigsti</surname><given-names>I. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Adenosine and autism -recent research and a new perspective</article-title>, in <source/>Autism—a Neurodevelopmental Journey from Genes to Behaviour, ed <person-group person-group-type="editor"><name><surname>Eapen</surname><given-names>V.</given-names></name></person-group> (InTech). Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.intechopen.com/books/autism-a-neurodevelopmental-journey-from-genes-to-behaviour/adenosine-and-autism-recent-research-and-a-new-perspective">http://www.intechopen.com/books/autism-a-neurodevelopmental-journey-from-genes-to-behaviour/adenosine-and-autism-recent-research-and-a-new-perspective</ext-link></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>M. P.</given-names></name><name><surname>Gleichmann</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondria in neuroplasticity and neurological disorders</article-title>. <source/>Neuron
<volume>60</volume>, <fpage>748</fpage>–<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.010</pub-id><pub-id pub-id-type="pmid">19081372</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>E. A.</given-names></name><name><surname>Tillisch</surname><given-names>K.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Gut/brain axis and the microbiota</article-title>. <source/>J. Clin. Invest.
<volume>125</volume>, <fpage>926</fpage>–<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1172/JCI76304</pub-id><pub-id pub-id-type="pmid">25689247</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDaniel</surname><given-names>S. S.</given-names></name><name><surname>Rensing</surname><given-names>N. R.</given-names></name><name><surname>Thio</surname><given-names>L. L.</given-names></name><name><surname>Yamada</surname><given-names>K. A.</given-names></name><name><surname>Wong</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway</article-title>. <source/>Epilepsia
<volume>52</volume>, <fpage>e7</fpage>–<lpage>e11</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.02981.x</pub-id><pub-id pub-id-type="pmid">21371020</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlane</surname><given-names>H. G.</given-names></name><name><surname>Kusek</surname><given-names>G. K.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Phoenix</surname><given-names>J. L.</given-names></name><name><surname>Bolivar</surname><given-names>V. J.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Autism-like behavioral phenotypes in BTBR T<sup>+</sup>tf/J mice</article-title>. <source/>Genes, brain, and behavior
<volume>7</volume>, <fpage>152</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00330.x</pub-id><pub-id pub-id-type="pmid">17559418</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyza</surname><given-names>K. Z.</given-names></name><name><surname>Defensor</surname><given-names>E. B.</given-names></name><name><surname>Jensen</surname><given-names>A. L.</given-names></name><name><surname>Corley</surname><given-names>M. J.</given-names></name><name><surname>Pearson</surname><given-names>B. L.</given-names></name><name><surname>Pobbe</surname><given-names>R. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The BTBR T<sup>+</sup><italic>tf</italic> /J mouse model for autism spectrum disorders-in search of biomarkers</article-title>. <source/>Behav. Brain Res.
<volume>251</volume>, <fpage>25</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2012.07.021</pub-id><pub-id pub-id-type="pmid">22958973</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Borjas</surname><given-names>L.</given-names></name><name><surname>Arrieta</surname><given-names>A.</given-names></name><name><surname>Saez</surname><given-names>L.</given-names></name><name><surname>Prassad</surname><given-names>A.</given-names></name><name><surname>Estevez</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title>[Clinical heterogeneity of the autistic syndrome: a study of 60 families]</article-title>. <source/>Invest. Clin.
<volume>33</volume>, <fpage>13</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="pmid">1391074</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname><given-names>S. S.</given-names></name><name><surname>Nadler</surname><given-names>J. J.</given-names></name><name><surname>Young</surname><given-names>N. B.</given-names></name><name><surname>Perez</surname><given-names>A.</given-names></name><name><surname>Holloway</surname><given-names>L. P.</given-names></name><name><surname>Barbaro</surname><given-names>R. P.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains</article-title>. <source/>Behav. Brain Res.
<volume>176</volume>, <fpage>4</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.07.030</pub-id><pub-id pub-id-type="pmid">16971002</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller-Schwarze</surname><given-names>A. B.</given-names></name><name><surname>Tandon</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Holmes</surname><given-names>G. L.</given-names></name><name><surname>Stafstrom</surname><given-names>C. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model</article-title>. <source/>Neuroreport
<volume>10</volume>, <fpage>1517</fpage>–<lpage>1522</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199905140-00023</pub-id><pub-id pub-id-type="pmid">10380973</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M. P.</given-names></name></person-group> (<year>2009</year>). <article-title>How mitochondria produce reactive oxygen species</article-title>. <source/>Biochem. J.
<volume>417</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id><pub-id pub-id-type="pmid">19061483</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mychasiuk</surname><given-names>R.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic modifications associated with ketogenic diet treatment in the BTBR<sup>T+Tf/J</sup> mouse model of autism spectrum disorder</article-title>. <source/>Autism Res. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1002/aur.1682</pub-id><pub-id pub-id-type="pmid">27529337</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napoli</surname><given-names>E.</given-names></name><name><surname>Duenas</surname><given-names>N.</given-names></name><name><surname>Giulivi</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Potential therapeutic use of the ketogenic diet in autism spectrum disorders</article-title>. <source/>Front. Pediatrics
<volume>2</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2014.00069</pub-id><pub-id pub-id-type="pmid">25072037</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nava</surname><given-names>C.</given-names></name><name><surname>Lamari</surname><given-names>F.</given-names></name><name><surname>Héron</surname><given-names>D.</given-names></name><name><surname>Mignot</surname><given-names>C.</given-names></name><name><surname>Rastetter</surname><given-names>A.</given-names></name><name><surname>Keren</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including <italic>TMLHE</italic></article-title>. <source/>Transl. Psychiatry
<volume>2</volume>, <fpage>e179</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2012.102</pub-id><pub-id pub-id-type="pmid">23092983</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naviaux</surname><given-names>R. K.</given-names></name><name><surname>Zolkipli</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Nakayama</surname><given-names>T.</given-names></name><name><surname>Naviaux</surname><given-names>J. C.</given-names></name><name><surname>Le</surname><given-names>T. P.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e57380</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0057380</pub-id><pub-id pub-id-type="pmid">23516405</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naviaux</surname><given-names>J. C.</given-names></name><name><surname>Schuchbauer</surname><given-names>M. A.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Risbrough</surname><given-names>V. B.</given-names></name><name><surname>Powell</surname><given-names>S. B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy</article-title>. <source/>Transl. Psychiatry
<volume>4</volume>, <fpage>e400</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2014.33</pub-id><pub-id pub-id-type="pmid">24937094</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naviaux</surname><given-names>J. C.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Bright</surname><given-names>A. T.</given-names></name><name><surname>Alaynick</surname><given-names>W. A.</given-names></name><name><surname>Williams</surname><given-names>K. R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Antipurinergic therapy corrects the autism-like features in the Fragile X (<italic>Fmr1</italic> knockout) mouse model</article-title>. <source/>Mol. Autism
<volume>6</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-6-1</pub-id><pub-id pub-id-type="pmid">25705365</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neal</surname><given-names>E. G.</given-names></name><name><surname>Chaffe</surname><given-names>H.</given-names></name><name><surname>Schwartz</surname><given-names>R. H.</given-names></name><name><surname>Lawson</surname><given-names>M. S.</given-names></name><name><surname>Edwards</surname><given-names>N.</given-names></name><name><surname>Fitzsimmons</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial</article-title>. <source/>Lancet Neurol.
<volume>7</volume>, <fpage>500</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(08)70092-9</pub-id><pub-id pub-id-type="pmid">18456557</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>S. B.</given-names></name><name><surname>Valakh</surname><given-names>V.</given-names></name></person-group> (<year>2015</year>). <article-title>Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>684</fpage>–<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id><pub-id pub-id-type="pmid">26291155</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname><given-names>C.</given-names></name><name><surname>Bomhof</surname><given-names>M. R.</given-names></name><name><surname>Reimer</surname><given-names>R. A.</given-names></name><name><surname>Hittel</surname><given-names>D. S.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Shearer</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder</article-title>. <source/>Mol. Autism
<volume>7</volume>:<fpage>37</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-016-0099-3</pub-id><pub-id pub-id-type="pmid">27594980</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Ebrahimi-Fakhari</surname><given-names>D.</given-names></name><name><surname>Di Nardo</surname><given-names>A.</given-names></name><name><surname>Julich</surname><given-names>K.</given-names></name><name><surname>Robson</surname><given-names>V. K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The stress-induced Atf3-gelsolin cascade underlies dendritic spine deficits in neuronal models of tuberous sclerosis complex</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>10762</fpage>–<lpage>10772</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4796-14.2015</pub-id><pub-id pub-id-type="pmid">26224859</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norkett</surname><given-names>R.</given-names></name><name><surname>Modi</surname><given-names>S.</given-names></name><name><surname>Birsa</surname><given-names>N.</given-names></name><name><surname>Atkin</surname><given-names>T. A.</given-names></name><name><surname>Ivankovic</surname><given-names>D.</given-names></name><name><surname>Pathania</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites</article-title>. <source/>J. Biol. Chem.
<volume>291</volume>, <fpage>613</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.699447</pub-id><pub-id pub-id-type="pmid">26553875</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nylen</surname><given-names>K.</given-names></name><name><surname>Velazquez</surname><given-names>J. L.</given-names></name><name><surname>Likhodii</surname><given-names>S. S.</given-names></name><name><surname>Cortez</surname><given-names>M. A.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Leshchenko</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype</article-title>. <source/>Exp. Neurol.
<volume>210</volume>, <fpage>449</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.11.015</pub-id><pub-id pub-id-type="pmid">18199435</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>G.</given-names></name><name><surname>Diogo</surname><given-names>L.</given-names></name><name><surname>Grazina</surname><given-names>M.</given-names></name><name><surname>Garcia</surname><given-names>P.</given-names></name><name><surname>Ataíde</surname><given-names>A.</given-names></name><name><surname>Marques</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Mitochondrial dysfunction in autism spectrum disorders: a population-based study</article-title>. <source/>Dev. Med. Child Neurol.
<volume>47</volume>, <fpage>185</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1017/S0012162205000332</pub-id><pub-id pub-id-type="pmid">15739723</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orinstein</surname><given-names>A. J.</given-names></name><name><surname>Helt</surname><given-names>M.</given-names></name><name><surname>Troyb</surname><given-names>E.</given-names></name><name><surname>Tyson</surname><given-names>K. E.</given-names></name><name><surname>Barton</surname><given-names>M. L.</given-names></name><name><surname>Eigsti</surname><given-names>I. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Intervention for optimal outcome in children and adolescents with a history of autism</article-title>. <source/>J. Dev. Behav. Pediatrics
<volume>35</volume>, <fpage>247</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1097/DBP.0000000000000037</pub-id><pub-id pub-id-type="pmid">24799263</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmieri</surname><given-names>L.</given-names></name><name><surname>Papaleo</surname><given-names>V.</given-names></name><name><surname>Porcelli</surname><given-names>V.</given-names></name><name><surname>Scarcia</surname><given-names>P.</given-names></name><name><surname>Gaita</surname><given-names>L.</given-names></name><name><surname>Sacco</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>38</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.63</pub-id><pub-id pub-id-type="pmid">18607376</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pancrazi</surname><given-names>L.</given-names></name><name><surname>Di Benedetto</surname><given-names>G.</given-names></name><name><surname>Colombaioni</surname><given-names>L.</given-names></name><name><surname>Della Sala</surname><given-names>G.</given-names></name><name><surname>Testa</surname><given-names>G.</given-names></name><name><surname>Olimpico</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Foxg1 localizes to mitochondria and coordinates cell differentiation and bioenergetics</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>13910</fpage>–<lpage>13915</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1515190112</pub-id><pub-id pub-id-type="pmid">26508630</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M. J.</given-names></name><name><surname>Aja</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Degano</surname><given-names>A. L.</given-names></name><name><surname>Penati</surname><given-names>J.</given-names></name><name><surname>Zhuo</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e109527</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0109527</pub-id><pub-id pub-id-type="pmid">25299635</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Maternal infection and immune involvement in autism</article-title>. <source/>Trends Mol. Med.
<volume>17</volume>, <fpage>389</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.001</pub-id><pub-id pub-id-type="pmid">21482187</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearl</surname><given-names>P. L.</given-names></name><name><surname>Gibson</surname><given-names>K. M.</given-names></name><name><surname>Acosta</surname><given-names>M. T.</given-names></name><name><surname>Vezina</surname><given-names>L. G.</given-names></name><name><surname>Theodore</surname><given-names>W. H.</given-names></name><name><surname>Rogawski</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Clinical spectrum of succinic semialdehyde dehydrogenase deficiency</article-title>. <source/>Neurology
<volume>60</volume>, <fpage>1413</fpage>–<lpage>1417</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000059549.70717.80</pub-id><pub-id pub-id-type="pmid">12743223</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percy</surname><given-names>A. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Rett syndrome: exploring the autism link</article-title>. <source/>Arch. Neurol.
<volume>68</volume>, <fpage>985</fpage>–<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2011.149</pub-id><pub-id pub-id-type="pmid">21825235</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilorge</surname><given-names>M.</given-names></name><name><surname>Fassier</surname><given-names>C.</given-names></name><name><surname>Le Corronc</surname><given-names>H.</given-names></name><name><surname>Potey</surname><given-names>A.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name><name><surname>De Gois</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>936</fpage>–<lpage>945</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.139</pub-id><pub-id pub-id-type="pmid">26370147</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poling</surname><given-names>J. S.</given-names></name><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Shoffner</surname><given-names>J.</given-names></name><name><surname>Zimmerman</surname><given-names>A. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Developmental regression and mitochondrial dysfunction in a child with autism</article-title>. <source/>J. Child Neurol.
<volume>21</volume>, <fpage>170</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1177/08830738060210021401</pub-id><pub-id pub-id-type="pmid">16566887</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial disease and epilepsy</article-title>. <source/>Dev. Med. Child Neurol.
<volume>54</volume>, <fpage>397</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2011.04214.x</pub-id><pub-id pub-id-type="pmid">22283595</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raichle</surname><given-names>M. E.</given-names></name><name><surname>Gusnard</surname><given-names>D. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Appraising the brain's energy budget</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>99</volume>, <fpage>10237</fpage>–<lpage>10239</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.172399499</pub-id><pub-id pub-id-type="pmid">12149485</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramoz</surname><given-names>N.</given-names></name><name><surname>Reichert</surname><given-names>J. G.</given-names></name><name><surname>Smith</surname><given-names>C. J.</given-names></name><name><surname>Silverman</surname><given-names>J. M.</given-names></name><name><surname>Bespalova</surname><given-names>I. N.</given-names></name><name><surname>Davis</surname><given-names>K. L.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Linkage and association of the mitochondrial aspartate/glutamate carrier <italic>SLC25A12</italic> gene with autism</article-title>. <source/>Am. J. Psychiatry
<volume>161</volume>, <fpage>662</fpage>–<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.161.4.662</pub-id><pub-id pub-id-type="pmid">15056512</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzuto</surname><given-names>R.</given-names></name><name><surname>De Stefani</surname><given-names>D.</given-names></name><name><surname>Raffaello</surname><given-names>A.</given-names></name><name><surname>Mammucari</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondria as sensors and regulators of calcium signalling</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>13</volume>, <fpage>566</fpage>–<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3412</pub-id><pub-id pub-id-type="pmid">22850819</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Melnyk</surname><given-names>S.</given-names></name><name><surname>Trusty</surname><given-names>T. A.</given-names></name><name><surname>Pavliv</surname><given-names>O.</given-names></name><name><surname>Seidel</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism</article-title>. <source/>Autism Res. Treat.
<volume>2012</volume>:<fpage>986519</fpage>. <pub-id pub-id-type="doi">10.1155/2012/986519</pub-id><pub-id pub-id-type="pmid">22928106</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Slattery</surname><given-names>J.</given-names></name><name><surname>Wynne</surname><given-names>R.</given-names></name><name><surname>Tippett</surname><given-names>M.</given-names></name><name><surname>Pavliv</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e85436</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085436</pub-id><pub-id pub-id-type="pmid">24416410</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossignol</surname><given-names>D. A.</given-names></name><name><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis</article-title>. <source/>Mol. Psychiatry
<volume>17</volume>, <fpage>290</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.136</pub-id><pub-id pub-id-type="pmid">21263444</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roullet</surname><given-names>F. I.</given-names></name><name><surname>Lai</surname><given-names>J. K.</given-names></name><name><surname>Foster</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>In utero</italic> exposure to valproic acid and autism–a current review of clinical and animal studies</article-title>. <source/>Neurotoxicol. Teratol.
<volume>36</volume>, <fpage>47</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2013.01.004</pub-id><pub-id pub-id-type="pmid">23395807</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Fortin</surname><given-names>J. A.</given-names></name><name><surname>Bisnauth</surname><given-names>S. N.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse</article-title>. <source/>Physiol. Behav.
<volume>168</volume>, <fpage>138</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2016.10.023</pub-id><pub-id pub-id-type="pmid">27836684</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e8349</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008349</pub-id><pub-id pub-id-type="pmid">20041135</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Svedova</surname><given-names>J.</given-names></name><name><surname>Cote</surname><given-names>J. L.</given-names></name><name><surname>Sandau</surname><given-names>U.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names><suffix>Jr.</suffix></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Ketogenic diet improves core symptoms of autism in BTBR mice</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e65021</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0065021</pub-id><pub-id pub-id-type="pmid">23755170</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Ramoz</surname><given-names>N.</given-names></name><name><surname>Barreto</surname><given-names>M.</given-names></name><name><surname>Gazdoiu</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Gertner</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title><italic>Slc25a12</italic> disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders</article-title>. <source/>Biol. Psychiatry
<volume>67</volume>, <fpage>887</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.08.042</pub-id><pub-id pub-id-type="pmid">20015484</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandin</surname><given-names>S.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Kuja-Halkola</surname><given-names>R.</given-names></name><name><surname>Larsson</surname><given-names>H.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The familial risk of autism</article-title>. <source/>JAMA
<volume>311</volume>, <fpage>1770</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.4144</pub-id><pub-id pub-id-type="pmid">24794370</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname><given-names>E.</given-names></name><name><surname>Turner</surname><given-names>K. L.</given-names></name><name><surname>Ramaraj</surname><given-names>A. B.</given-names></name><name><surname>Murphy</surname><given-names>M. P.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name><name><surname>Kaphzan</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial superoxide contributes to hippocampal synaptic dysfunction and memory deficits in Angelman syndrome model mice</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>16213</fpage>–<lpage>16220</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2246-15.2015</pub-id><pub-id pub-id-type="pmid">26658871</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segurado</surname><given-names>R.</given-names></name><name><surname>Conroy</surname><given-names>J.</given-names></name><name><surname>Meally</surname><given-names>E.</given-names></name><name><surname>Fitzgerald</surname><given-names>M.</given-names></name><name><surname>Gill</surname><given-names>M.</given-names></name><name><surname>Gallagher</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier <italic>SLC25A12</italic> gene on chromosome 2q31</article-title>. <source/>Am. J. Psychiatry
<volume>162</volume>, <fpage>2182</fpage>–<lpage>2184</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.162.11.2182</pub-id><pub-id pub-id-type="pmid">16263864</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>J. M.</given-names></name><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><name><surname>Ramoz</surname><given-names>N.</given-names></name><name><surname>Schmeidler</surname><given-names>J.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphism</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>147</volume>, <fpage>408</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30614</pub-id><pub-id pub-id-type="pmid">17894412</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>J. D.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name><name><surname>Mychasiuk</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Inchworming: a novel motor stereotypy in the BTBR <italic>T</italic><sup>+</sup>
<italic>Itpr3</italic><sup><italic>tf</italic></sup>/<italic>J</italic> mouse model of autism</article-title>. <source/>J. Visual. Exp.
<fpage>50791</fpage>. <pub-id pub-id-type="doi">10.3791/50791</pub-id><pub-id pub-id-type="pmid">25046063</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spilioti</surname><given-names>M.</given-names></name><name><surname>Evangeliou</surname><given-names>A. E.</given-names></name><name><surname>Tramma</surname><given-names>D.</given-names></name><name><surname>Theodoridou</surname><given-names>Z.</given-names></name><name><surname>Metaxas</surname><given-names>S.</given-names></name><name><surname>Michailidi</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD)</article-title>. <source/>Front. Hum. Neurosci.
<volume>7</volume>:<fpage>858</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2013.00858</pub-id><pub-id pub-id-type="pmid">24399946</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafstrom</surname><given-names>C. E.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The ketogenic diet as a treatment paradigm for diverse neurological disorders</article-title>. <source/>Front. Pharmacol.
<volume>3</volume>:<fpage>59</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2012.00059</pub-id><pub-id pub-id-type="pmid">22509165</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stromland</surname><given-names>K.</given-names></name><name><surname>Nordin</surname><given-names>V.</given-names></name><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Akerstrom</surname><given-names>B.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>Autism in thalidomide embryopathy: a population study</article-title>. <source/>Dev. Med. Child Neurol.
<volume>36</volume>, <fpage>351</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.1994.tb11856.x</pub-id><pub-id pub-id-type="pmid">8157157</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><name><surname>Coskun</surname><given-names>P. E.</given-names></name><name><surname>Vesa</surname><given-names>J.</given-names></name><name><surname>Gold</surname><given-names>J.-A.</given-names></name><name><surname>Jiang</surname><given-names>Y.-H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Mitochondrial dysfunction in CA1 hippocampal neurons of the <italic>UBE3A</italic> deficient mouse model for Angelman syndrome</article-title>. <source/>Neurosci. Lett.
<volume>487</volume>, <fpage>129</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.06.079</pub-id><pub-id pub-id-type="pmid">19563863</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>M.</given-names></name><name><surname>Timmerman</surname><given-names>C. K.</given-names></name><name><surname>Schwartz</surname><given-names>J. L.</given-names></name><name><surname>Pham</surname><given-names>D. L.</given-names></name><name><surname>Meffert</surname><given-names>M. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Characterizing autism spectrum disorders by key biochemical pathways</article-title>. <source/>Front. Neurosci.
<volume>9</volume>:<fpage>313</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2015.00313</pub-id><pub-id pub-id-type="pmid">26483618</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suen</surname><given-names>D. F.</given-names></name><name><surname>Norris</surname><given-names>K. L.</given-names></name><name><surname>Youle</surname><given-names>R. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial dynamics and apoptosis</article-title>. <source/>Genes Dev.
<volume>22</volume>, <fpage>1577</fpage>–<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1658508</pub-id><pub-id pub-id-type="pmid">18559474</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>G.</given-names></name><name><surname>Gutierrez Rios</surname><given-names>P.</given-names></name><name><surname>Kuo</surname><given-names>S.-H.</given-names></name><name><surname>Akman</surname><given-names>H. O.</given-names></name><name><surname>Rosoklija</surname><given-names>G.</given-names></name><name><surname>Tanji</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Mitochondrial abnormalities in temporal lobe of autistic brain</article-title>. <source/>Neurobiol. Dis.
<volume>54</volume>, <fpage>349</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.01.006</pub-id><pub-id pub-id-type="pmid">23333625</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tigerholm</surname><given-names>J.</given-names></name><name><surname>Borjesson</surname><given-names>S. I.</given-names></name><name><surname>Lundberg</surname><given-names>L.</given-names></name><name><surname>Elinder</surname><given-names>F.</given-names></name><name><surname>Fransen</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Dampening of hyperexcitability in CA1 pyramidal neurons by polyunsaturated fatty acids acting on voltage-gated ion channels</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e44388</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0044388</pub-id><pub-id pub-id-type="pmid">23049748</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tordjman</surname><given-names>S.</given-names></name><name><surname>Somogyi</surname><given-names>E.</given-names></name><name><surname>Coulon</surname><given-names>N.</given-names></name><name><surname>Kermarrec</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>D.</given-names></name><name><surname>Bronsard</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Gene x Environment interactions in autism spectrum disorders: role of epigenetic mechanisms</article-title>. <source/>Front. Psychiatry
<volume>5</volume>:<fpage>53</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2014.00053</pub-id><pub-id pub-id-type="pmid">25136320</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turunen</surname><given-names>J. A.</given-names></name><name><surname>Rehnstrom</surname><given-names>K.</given-names></name><name><surname>Kilpinen</surname><given-names>H.</given-names></name><name><surname>Kuokkanen</surname><given-names>M.</given-names></name><name><surname>Kempas</surname><given-names>E.</given-names></name><name><surname>Ylisaukko-Oja</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial aspartate/glutamate carrier SL<italic>C25A12</italic> gene is associated with autism</article-title>. <source/>Autism Res.
<volume>1</volume>, <fpage>189</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1002/aur.25</pub-id><pub-id pub-id-type="pmid">19360665</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veenstra-Vanderweele</surname><given-names>J.</given-names></name><name><surname>Christian</surname><given-names>S. L.</given-names></name><name><surname>Cook</surname><given-names>E. H.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2004</year>). <article-title>Autism as a paradigmatic complex genetic disorder</article-title>. <source/>Annu. Rev. Genomics Hum. Genet.
<volume>5</volume>, <fpage>379</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.5.061903.180050</pub-id><pub-id pub-id-type="pmid">15485354</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Voskuyl</surname><given-names>R. A.</given-names></name><name><surname>Vreugdenhil</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Effects of essential fatty acids on voltage-regulated ionic channels and seizure thresholds in animals</article-title>, in <source/>Fatty Acids: Physiological and Behavioral Functions, eds <person-group person-group-type="editor"><name><surname>Mostofsky</surname><given-names>D.</given-names></name><name><surname>Yehuda</surname><given-names>S.</given-names><suffix>Jr.</suffix></name><name><surname>Salem</surname><given-names>N.</given-names></name></person-group> (<publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>63</fpage>–<lpage>78</lpage>.</mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>S. E.</given-names></name><name><surname>Sena</surname><given-names>L. A.</given-names></name><name><surname>Chandel</surname><given-names>N. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondria in the regulation of innate and adaptive immunity</article-title>. <source/>Immunity
<volume>42</volume>, <fpage>406</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.02.002</pub-id><pub-id pub-id-type="pmid">25786173</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Alshikho</surname><given-names>M. J.</given-names></name><name><surname>Herbert</surname><given-names>M. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Pathway network analyses for autism reveal multisystem involvement, major overlaps with other diseases and convergence upon MAPK and calcium signaling</article-title>. <source/>PLoS ONE
<volume>11</volume>:<fpage>e0153329</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0153329</pub-id><pub-id pub-id-type="pmid">27055244</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S.</given-names></name><name><surname>Napoli</surname><given-names>E.</given-names></name><name><surname>Krakowiak</surname><given-names>P.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><name><surname>Giulivi</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of <italic>p53</italic>, mitochondrial DNA deletions, and paternal age in autism: a case-control study</article-title>. <source/>Pediatrics
<volume>137</volume>:<fpage>e20151888</fpage>. <pub-id pub-id-type="doi">10.1542/peds.2015-1888</pub-id><pub-id pub-id-type="pmid">27033107</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname><given-names>J. M.</given-names></name><name><surname>Rodrigues</surname><given-names>C. M. P.</given-names></name><name><surname>Solá</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondria: major regulators of neural development</article-title>. <source/>Neuroscientist
<volume>22</volume>, <fpage>346</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1177/1073858415585472</pub-id><pub-id pub-id-type="pmid">25948649</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Jones</surname><given-names>A.</given-names></name><name><surname>Deeney</surname><given-names>J. T.</given-names></name><name><surname>Hur</surname><given-names>S. K.</given-names></name><name><surname>Bankaitis</surname><given-names>V. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Inborn Errors of Long-Chain fatty acid β-oxidation link neural stem cell self-renewal to autism</article-title>. <source/>Cell Rep.
<volume>14</volume>, <fpage>991</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.004</pub-id><pub-id pub-id-type="pmid">26832401</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X. P.</given-names></name><name><surname>Sun</surname><given-names>R. P.</given-names></name><name><surname>Jin</surname><given-names>R. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Effect of ketogenic diet on hippocampus mossy fiber sprouting and GluR5 expression in kainic acid induced rat model</article-title>. <source/>Chinese Med. J.
<volume>119</volume>, <fpage>1925</fpage>–<lpage>1929</lpage>. <pub-id pub-id-type="pmid">17134593</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yudkoff</surname><given-names>M.</given-names></name><name><surname>Daikhin</surname><given-names>Y.</given-names></name><name><surname>Melo</surname><given-names>T. M.</given-names></name><name><surname>Nissim</surname><given-names>I.</given-names></name><name><surname>Sonnewald</surname><given-names>U.</given-names></name><name><surname>Nissim</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect</article-title>. <source/>Annu. Rev. Nutr.
<volume>27</volume>, <fpage>415</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.nutr.27.061406.093722</pub-id><pub-id pub-id-type="pmid">17444813</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Fung</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Shin</surname><given-names>B.-C.</given-names></name><name><surname>Thamotharan</surname><given-names>S.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>286</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.51</pub-id><pub-id pub-id-type="pmid">19506559</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>